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CHAPTER I 
 
INTRODUCTION 
 
Proteomics 
Proteomics is the study of the proteome, which contains all of the proteins 
derived from a genome. Proteomics involves the study of multiprotein systems, 
the interactions between the components of these systems, and their role as part 
of a larger network. This includes, among other things, identification of proteins 
from a known genome, mapping of post translational modifications, and 
comparison of protein expression in different cell states.1 There are two general 
approaches to proteomics analyses, bottom-up and top-down. Bottom-up 
proteomics is the most widely used and involves enzymatic digestion of the 
proteins into peptides prior to mass spectrometry analysis. Protein identification 
is achieved by the use of database search algorithms. “Top-down” protein 
identification approaches, which have been developed more recently, involve the 
mass spectrometry analysis of the intact proteins without prior digestion.2  
 
Bottom-up proteomics 
 
 The first step in a bottom-up method involves isolation of the protein of 
interest using separation techniques such as 2D polyacrylamide gel 
electrophoresis (2D-PAGE), ion-exchange chromatography, and reverse phase 
chromatography.1  2D-PAGE consists of a combination of separation by 
isoelectric point and size. The isoelectric point of a protein is the point at which 
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there is an equal distribution of positive and negative charges throughout the 
protein resulting in a zero net charge. In the Isoelectric point separation step, a 
protein mixture is applied to a strip of polyacrylamide gel containing an 
immobilized pH gradient. This immobilized pH gradient gel (IPG) contains 
acrylamide derivatives that have buffering moieties with a specific pKa directly 
incorporated into the gel. As voltage is applied, the proteins will focus at the 
points on the gel where they are neutral. In a 2D-SDS-PAGE experiment, the 
proteins are applied to an IPG strip in the first step, then the strip is treated with 
the buffer containing sodium dodecyl sulfate (SDS) and jointed to the SDS-PAGE 
part of the gel, where they are resolved by size. In size separation, the proteins 
associate with SDS forming micelles of size according to their molecular weights.  
By this process the proteins are given a net negative charge which increases in 
magnitude with increasing size. A voltage is applied which causes the negatively 
charged micelles to migrate through the gel towards the positive electrode, with 
the low molecular weight proteins moving faster than the high molecular weight 
proteins.  The gel is then stained by conventional techniques such as silver, 
coomassie, and amido black stains.3-5  
Once a mixture of proteins has been resolved, the different proteins are 
digested with a protease, typically trypsin. This is a serine protease which 
cleaves at the C-terminus of lysine and arginine, unless followed by proline. The 
digestion is done either in solution after extraction of the proteins from the gel, or 
directly in the gel (“in gel digestion”).3, 5  Alternatively, the proteins can be 
digested prior to separation, this is referred to as the “shot-gun” approach (Figure 
 2
I-1).6  In this approach the separation is done at the peptide level by tandem 
liquid chromatographic techniques, involving ion-exchange and reverse-phase 
chromatography.  In ion exchange chromatography, the peptides are separated 
by charge.  A resin with immobilized charged groups is used and elution of the 
peptides is done by varying the ionic strength of the buffer.  For peptides, cation-
exchange chromatography is the method of choice. The resins used typically 
contain an immobilized negatively charged group such as sulfate or carboxylate.  
Peptides with multiple positive charges will adhere more strongly to the resin and 
will require a higher ionic strength for elution than singly charged peptides. 7 
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Figure I-1. Schematics of shot-gun proteomics. 
 
 
        Reverse-phase liquid chromatography (RP-LC) separates molecules 
based on hydrophobicity. The packing material for RP-LC consists of large 
hydrocarbon chains immobilized on silica.  Hydrophobic peptides then have a 
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higher affinity for the packing material and elute later than more polar peptides.3 
Tandem LC coupled to mass spectrometry, has been shown to be very effective 
for the analysis of complex peptide mixtures.  Yates et al. describes a tandem 
LC-MS method that combines ion exchange LC and RP-LC.8  First a peptide 
mixture is applied to a strong cation-exchange microcapillary column. Peptides 
are eluted by a step gradient where the salt concentration of the buffer is 
increased. With each step, a group of peptides is eluted which then passes on to 
a RP microcapillary column for further separation and then to the mass 
spectrometer (Figure I-2). This approach provides high resolution analysis and 
allows for a larger number of peptides to be identified in a single run compared to 
RP-LC alone.8, 9 
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Figure I-2. Illustration of the use of on-line ion-exchange and reverse-phase HPLC for shot-gun 
proteomics. 
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Mass spectrometry 
 
 In order to understand proteomics analyses it is necessary to have an 
understanding of the different mass spectrometry techniques and how they are 
applied to protein identification. 
 The first step in mass spectrometry analyses requires the ionization of the 
analyte into the gas-phase. There are numerous methods for ionization, however 
electrospray ionization (ESI) and matrix assisted desorption ionization (MALDI) 
are the most widely used in proteomics and will be discussed in such context. In 
positive ESI, the analyte (usually a peptide mixture), is introduced as an acidic 
aqueous solution. The sample is passed through a small-diameter needle, where 
a high, positive voltage is applied causing the sample to spray out into a mist of 
droplets. These droplets contain peptide ions as well as the sample solvent. The 
acidic conditions cause the droplets to have a net positive charge which results in 
their movement towards the negatively charged inlet of the instrument. 
Evaporation reduces the size of the droplets which causes the splitting of these 
into smaller charged droplets. This process occurs several times with the aid of a 
flow of nitrogen and heat until dessolvated gas-phase peptide ions are obtained. 
These are then directed into the mass analyzer.10  ESI generally produces 
multiply charged species, and the number of charges in the case of peptides and 
proteins, is influenced by the presence of basic amino acid residues such as 
arginine and lysine. One of the advantages of this ionization method in 
proteomics is its compatibility with HPLC separations. 
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ESI can be coupled to several mass analyzers; however, the most 
commonly used in bottom-up proteomics are the triple-quadrupole and the ion- 
trap analyzers. The triple-quadrupole analyzer is composed of three 
quadrupoles, which consist of four metal rods arranged in parallel (Figure I-3).  
An electric field is established through the quadrupole by applying direct current 
(DC) and radio frequency (RF) voltages simultaneously. The electric field causes 
ions of a certain m/z value to have a stable cork-screw like trajectory throughout 
the field, while other ions of different m/z move outwards and get lost by a variety 
of mechanisms. Varying the RF/DC potential applied to the rods will determine 
what ions get through the quadrupole.  In a triple-quadrupole analyzer, only two 
quadrupoles are subjected to DC and RF voltages, one is located at the entrance 
of the analyzer (Q1) and the other at the exit (Q3). The quadrupole located in the 
middle (Q2) is used as a collision cell in collision-induced dissociation (CID) 
where ions can be subjected to collisions with argon gas atoms to induce 
fragmentation.11-13  A full scan can be done to obtain information about all the 
ions present in a sample at a given time.  The instrument achieves this by 
scanning all the ions passing through Q1.  This quadrupole can also be used as 
a mass filter to allow only one ion to pass through to Q2. For CID experiments, 
Q1 is used to select the ion of interest, which then passes to the collision cell 
(Q2) and gets fragmented.  The fragment ions are then scanned in Q3.11 In an 
ESI triple-quadrupole instrument, fragmentation of certain ion species can also 
occur at the source when enough voltage is applied, due to the relatively high 
gas pressure in the source. This phenomenon is referred to as in-source CID.14  
 6
sheath gas
aux gas
ESI probe
octapole
lens
Q2
collision cell
Q3
Daughter 
mass analyzer
dynode &
electron 
multiplier
tube
lens
heated 
capillary
analyte
atmospheric 
pressure 
region
Q1
Parent 
mass analyzer
capillary-
skimmer
region
mass analyzer region
 
Figure I-3. Schematics of the basic components of an ESI-triple-quadrupole mass spectrometer. 
 
 
The ion-trap analyzer consists of two conical electrodes and one ring 
electrode (Figure I-4). The ions are held in the small interior volume between the 
conical electrodes. By lowering and raising the voltages on the entrance and exit 
trap electrodes, ions pass through the trap, are stored for a period of time (μs to 
sec), and are released into the detector. Ions of a certain m/z are selectively 
released from the trap in the mass selective stability mode.  One of the main 
advantages of the ion-trap is that it allows for multiple CID (MS/MS) events 
(MSn).  Product ions from a first MS/MS event can be stored, reactivated in 
another MS/MS event and so on.15 
Matrix Assisted Desorption Ionization (MALDI) requires the incorporation 
of the peptide sample into a matrix composed of crystalline UV-absorbing 
molecules. The most common matrices are α-cyano-4-hydroxycinnamic acid, 
sinapinic acid (3,5-dimethoxy-4-hydroxycinnamic acid), and 2,5-dihydroxybenzoic 
acid. These molecules must absorb at the wavelength of the laser, which is 
normally 337nm for a nitrogen laser. When the laser hits the matrix crystals, they 
absorb energy in the form of photons, which is emitted as heat. Rapid heating 
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causes expansion of the matrix and peptide molecules into the gas phase, where 
energy is transferred from the photoionized matrix molecules to the peptide 
molecules, which in turn get ionized. 16 This ionization method generates mostly 
singly charged ions, although some doubly and triply charged protein ions are 
observed. The mass analyzer typically coupled with MALDI is the time-of-flight 
(TOF). 
 
 
Figure I-4. Schematics of an ESI-ion-trap mass spectrometer. 
 
 
The time-of-flight mass analyzer separate ions and measures their m/z 
based on the time they take to pass from the ion source to the detector.  Ions are 
generated in the source and flown down the flight tube under the influence of an 
accelerating potential.  To increase mass resolution, a reflectron is introduced at 
the end of the tube.  Once the ions reach the reflectron, they are gradually 
repelled back to a second detector (Figure I-5). MS/MS experiments are possible 
by combining two TOF analyzers (MALDI-TOF-TOF). 11, 17 
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 Figure I-5. Schematics of a reflectron MALDI-TOF mass spectrometer 
 
 
Mass Spectrometry Analysis in Proteomics 
 
 Mass spectrometry analysis is the most important step in protein 
identification. The two most common protein identification methods through 
peptide analysis are peptide mass finger printing and peptide sequencing by 
tandem mass spectrometry.13 In peptide mass fingerprinting the peptides derived 
from an enzymatic protein digestion are analyzed typically by a MALDI-TOF for 
accurate mass measurements. The parent protein then is identified by matching 
the measured peptide masses to the corresponding peptide masses from a 
protein database. This database contains a great number of known protein 
sequences derived from known genomes. By performing a theoretical digestion 
of all the proteins in the database, a list of peptide sequences with their 
corresponding m/z’s is generated which is compared to the experimental peptide 
m/z’s. Protein identification in this manner is very dependant in the accuracy of 
the peptide m/z measurements and available databases. In addition, false 
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positive matches are common due to the complexity of the MS spectra. 
Nevertheless, this approach allows for fast and relatively simple protein 
identification. 4, 18, 19 
 A more useful, yet more complex approach to protein identification 
involves peptide sequencing by tandem mass spectrometry. This is carried out 
using ESI-triple quadrupole or ESI-ion-trap instruments. The latter is commonly 
the best choice for shot-gun proteomics analyses due to better sensitivity and 
automatization of data acquisition.  In this approach, not only peptide masses are 
measured, but CID fragmentation patterns are obtained which are used to 
determine the amino acid composition through database search algorithms. ESI-
ion trap instruments allow for high throughput analysis with data dependant 
scanning (FigureI-6). In data dependant mode, first a full spectrum is obtained of 
all the m/z’s present at a certain LC retention time, then the software selects the 
most abundant ions in the full spectrum to perform MS/MS.   A great amount of 
data is generated in this manner with a single sample injection. This approach 
has the advantage over peptide mass fingerprinting of better accuracy of protein 
identification with reduced false positive matches. In addition, its applications are 
not limited only to protein identification; other information such as sites of 
posttranslational modifications can be obtained. 6 
 
Peptide fragmentation and protein identification 
 
 In collision induced dissociation (CID), ions are activated by collisions with 
neutral gas molecules. Peptide ions dissociate under CID conditions generating a 
 10
series of predictable backbone fragments. These fragments are used to deduce 
the amino acid composition of the peptide.   
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FigureI-6. General illustration of data-dependant scanning with an ESI-ion-trap 
instrument. 
 
 
Peptide fragmentation along the backbone is the most important for 
sequencing analyses. However, numerous other fragments can be present in an 
MS/MS spectrum. A diagram showing peptide fragmentation nomenclature is 
shown in  
Figure I-7.  Cleavage of the bond between the carbonyl carbon and the 
amide nitrogen to form b and y-ions is the most common in CID. These 
fragments are the most important for peptide sequencing; therefore algorithms 
are optimized for this type of fragmentation. In the y-ion series, the positive 
charge of the C-terminus of the peptide is retained.  The b-ion series contains the 
charged N-terminus. The ion number indicates the number of amino acids 
present. For example b1, b2, and b3 ions contain 1, 2, and 3 amino acids 
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respectively. b- and y-ions are complementary and provide a pattern in which m/z 
gaps between consecutive fragments correspond to the amino acids in the 
sequence. Under ESI conditions, multiple charged ions are observed.  Multiply 
charged peptide ions provide more information in CID spectra than singly 
charged peptide ions, since neutral fragments are lost and not observed in the 
spectra.13, 19  
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Figure I-7.Peptide fragmentation nomenclature 
 
Protein identification using MS/MS spectra can be done in two ways, by 
de novo sequencing and by the use of search algorithms. In de novo sequencing, 
peptide sequences are determined by manually inspecting the MS/MS data or 
with the help of de novo sequencing software such as Lutefisk.20  Then the 
protein sequence is matched to homologous sequences in a genome database 
using the BLAST search algorithm.21  This process is very lengthy and inefficient 
compared to automated analysis of MS/MS data by search algorithms such as 
SEQUEST.22 However, it can be useful when only a small set of data is being 
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analyzed, or when the genome of the organism being studied is not known.23  In 
SEQUEST algorithm searches, b- and y-ions of peptides are matched with 
theoretical b- and y-ions of the corresponding peptides in the protein database. 
This approach allows for analysis of a much greater amount of MS/MS spectra, 
and it is the most widely used.12 
 
Database search algorithms and other data manipulation software 
 
SEQUEST is the most widely used database search algorithm.  The way 
this search algorithm works is by comparing MS/MS spectra to theoretical 
MS/MS spectra available from a protein database.  First one must specify the 
digestion enzyme, typically trypsin. The program then performs a theoretical 
digestion of all the proteins available for a certain database, for example, human, 
bovine etc… A list of peptides from all the proteins is generated, then a list of 
theoretical b- and y-ions for each peptide. The program matches the precursor 
peptide ion m/z to possible peptides from the list, and the MS/MS spectra are 
compared to theoretical spectra. A correlation score is calculated that tells how 
accurate the match is.  Peptide sequences are then matched to proteins in the 
database.22 Although this software simplifies and speeds up data analysis 
tremendously, it cannot decide whether the data is significant.  However the 
probability of a legitimate match increases with increasing number of matched 
peptides with good correlation scores.  There are other problems associated with 
using SEQUEST, and that is the issue of post-translational modifications. 
Unexpected post-translational modifications may not be accounted for in the 
matching process and this would disrupt protein identification. However, it is 
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possible to account for known modifications such as phosphorylation, cysteine 
oxidation, and glycosylation by modifying search parameters. Nevertheless, 
SEQUEST has proven to be a great tool for proteomics analyses allowing for 
manipulation of enormous amount of data in relatively short time.13, 24 
 Often in proteomics there is an interest not only on identifying proteins in a 
biological sample, but also specific features such as post-translational 
modifications and protein adducts. There is spectra manipulation software that 
has been designed for this purpose such as SALSA25 (Scoring Algorithm for 
Spectral Analysis) and P-Mod26. SALSA is used for finding specific features in 
the MS/MS spectra. These features can be a product ion having a specific m/z, a 
neutral loss, which would be a m/z difference between the precursor ion and a 
fragment present in the MS/MS spectrum, a charged loss, and an ion pair, which 
are two fragments with a m/z difference equal to the m/z of a certain amino acid. 
SALSA identifies these characteristics in all of the MS/MS spectra and scores the 
data according to the number of characteristics matched and peak intensities.25 
This is a great tool for analyzing mass spectral data and obtaining specific 
information about the protein that may be missed by SEQUEST.  
 The p-Mod software was designed specifically for mapping of post-
translational modifications.  In this case, the protein identity is known. The user 
inputs the protein sequence and performs a theoretical digestion to generate a 
list of peptides.  The software matches the experimental data to the theoretical 
peptide list and identifies m/z differences between the MS/MS precursor ions and 
the m/z of the precursors generated on the theoretical list. It also identifies the 
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location of the modification in the sequence by detecting the mass shift in the b- 
and y-ions. A p-value is calculated which reflects the probability of a false 
positive match.26  
Bottom-up proteomics is the most widely used approach for protein 
identification. On-line multidimensional capillary HPLC methods used for shot-
gun approaches as described above, allow for high resolution separations and 
fully automated, high throughput analyses. Moreover, bioinformatics tools are 
optimized for bottom-up strategies. However there are several limitations to this 
tactic. First, these methods seldom provide high sequence coverage of the 
protein. Although only a fraction of the peptides derived form a given protein is 
necessary for identification, a lot of information is lost in the analysis. For 
example, post translational modifications may not be represented in the peptide 
population ultimately identified.  Peptides of low abundance are also suppressed 
by high-abundance peptides in the MS spectra.  And although bottom-up 
analyses are high throughput, on-line multistep chromatography separations still 
require extended run times (hours).27 Top-down approaches offer solutions to 
these problems, however, they are not yet well established and new techniques 
and improvements are still needed for these approaches to become more widely 
used.28 
 
Top-Down Proteomics 
 
Top-down proteomics involves the direct molecular weight measurement 
of intact proteins followed by fragmentation of the protein ions in the gas-phase. 
Fragmentation of intact protein ions was first demonstrated for ribonuclease A 
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using an ESI-triple quadrupole instrument.29 However, the product ion spectra 
derived from multiply charged protein ions are very complex, and without high 
mass resolution, assignment of product ion charge states is not possible.  To 
overcome this problem two approaches have been developed. One is the use of 
more powerful instruments such as fourier transform mass spectrometers (FT-
ICR MS) 30 and the other is charge state manipulation. 
 
Charge state manipulation 
 
Gas-phase ion chemistry makes possible the use of low resolving power 
mass analyzers such as triple-quadrupoles and ion-traps for obtaining sequence 
information of whole intact proteins.  Ion-Ion proton transfer is the most 
commonly used charge manipulation technique for reducing multiple charged 
product ions to their singly charged state.  In this reaction a proton from a 
multiply charged cation is transferred to a singly charged anion to give a reduced 
charge cation and a neutral species (Equation 1). This ion chemistry is achieved 
with the modification of the mass spectrometer to include an atmospheric 
sampling glow discharge ionization source (ASGDI) to introduce negative ions 
into the mass analyzer. This has been more widely achieved with ESI-ion-traps; 
however it has also been shown with a triple-quadrupole mass analyzer. This 
technique has also been useful for charge state manipulation of protein precursor 
ions.  Where charge states can be concentrated and purified for dissociation.  
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(M + nH+)n+ + A-              (M + (n-1)H+)(n-1)+ + HA                                                 [1] 
                     
High-resolution product ion mass determination 
 
Very high isotopic mass resolution can be achieved with a Fourier-
Transform Ion Cyclotron Resonance mass analyzer (FTICR). This is typically 
combined with an ESI source and it is commonly used in top-down proteomics. In 
FTICR, ions are trapped in a magnetic field where they oscillate at a certain 
frequency, adopting stable cyclotron orbits.  The ions then get excited to a 
greater cyclotron radius by applying an oscillating electric field. The signal is 
detected as an image current on a pair of plates which the packet of ions passes 
close to. The ions are excited simultaneously by applying a wide range of 
excitation energies at once. The signal is a multiple ion wave plot of the 
amplitude of the frequency over time. Fourier transform is then used to produce a 
mass spectrum. 
 
 
Figure I-8. Schematics of a FT-ICR instrument. 
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 High magnetic field strength FT-ICR instruments offer very high resolving 
power and provide high mass accuracy. With these instruments, it is possible to 
determine isotope spacing of high mass ions and product ions, therefore charge 
state determinations are feasible. Also, unit mass resolutions allow for 
identification of disulfide bridges, deamination, and other post-translational 
modifications.  
Electron capture dissociation (ECD) is used for the dissociation of ions as 
opposed to CID.  In this method, ions pass through a high-current electron beam 
and are activated by ion-electron collisions. The result is fragmentation of N-Cα 
bonds along the backbone to form mainly c- and z- type ions.  ECD provides 
greater sequence coverage than CID (more bonds are cleaved) and allows 
preservation of post-translational modifications. 31 
The main advantage of top-down over bottom-up methods is the higher 
sequence coverage obtained. The entire protein is available for sequencing and 
not just a small population of abundant peptides. In addition, bypassing all the 
preparative steps associated with bottom-up methods greatly reduces analysis 
time.32 However, this approach is not as mature as bottom-up strategies and is 
limited by a great number of factors. First of all, FT-ICR instruments are highly 
sophisticated and very expensive, which limits the access to these to a very few 
number of research laboratories. Another problem with top-down proteomics is 
the need to separate small quantities of complex protein mixtures and yet obtain 
samples compatible with ESI.  Therefore direct protein MS analysis is so far 
limited to isolated proteins or simple mixtures. In addition, mass accuracy and 
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resolution decrease as molecular weight increases, therefore identification of 
very large proteins remains challenging.   Alternatively, hybrid methods have 
been shown to provide the best of both worlds. VerBerkmoes et al. reports the 
identification of 868 proteins from the bacterium S. oneidensis using a 
combination of the shot-gun method and FT-ICR techniques.33 Nevertheless top-
down proteomics methods continue to improve and have become more common 
in the past few years.34  
 
Radical Degradation of Proteins 
 
Radicals are formed generally either by homolytic bond cleavage which is 
induced by the absorption of energy (thermolysis or photolysis), or by electron 
transfer reactions.  Radicals can undergo numerous processes such as 
substitution, addition, rearrangement, elimination and fragmentation.35  These 
reactions are important in chemical as well as in biological systems.  In 
chemistry, radical reactions have been useful in the synthesis of organic 
molecules and in radical polymerization reactions. In biology, radicals are 
involved in reactions with biomolecules such as proteins, lipids, and nucleic 
acids, which can lead to damage and degradation.  
 
Radical sources 
 
Chemical bonds are cleaved to form radicals upon absorption of energy 
such as heat or radiation; however, some bonds do this more readily than others. 
The most common bonds to undergo homolysis are the peroxy bond and the azo 
bond. Such linkages serve as initiators for other radical processes.35 The 
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peroxide bond is a particularly weak bond with bond dissociation energies of 30 
to 35 Kcal/mol.35 Diacyl peroxides are known to undergo decomposition in 
solution and in the gas-phase via homolytic or heterolytic pathways to give free 
radicals. 36, 37 Homolysis of acylperoxides typically results in carboxyl radicals 
which further decompose to release CO2 and a carbon-centered radical.  The 
carbon radical can then couple to another carbon radical or trap another carboxyl 
radical. Peroxycarbamates  have been shown to undergo thermal decomposition 
in a similar fashion by first cleavage of the O-O bond and loss of CO2 to form a 
nitrogen-centered radical and an alkoxyl radical.38 Scheme I-1 shows general 
equations for all homolytic cleavages discussed above. 
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Scheme I-1. Homolytic cleavage reactions: A) decomposition of alkyl peroxides, B) 
decomposition of azo compounds, C) homolysis of diacyl peroxides, D) decomposition of t-butyl 
peroxycarbamates. 
 
 
 
Carbon-centered radicals 
 
Radical reactions with peptides and proteins normally give rise to carbon-
centered radicals at either an amino acid side chain or a backbone α-carbon.  
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The carbon-centered radicals are most commonly formed by abstraction of a 
hydrogen by another radical species inter- or intra-molecularly.39  The fate of the 
carbon-centered radicals is controlled by a number of processes, which include 
fragmentation of the backbone.  For example, it has been shown that exposure of 
proteins to radiolytically generated HO. in the presence of O2 leads to 
fragmentation of the proteins.39 In another study, it was found that alkoxyl 
radicals formed at the C-3 position on aliphatic amino acid side chains lead to the 
formation of carbon-centered radicals that can undergo β-scission, resulting in 
backbone cleavage and loss of the amino acid side chain (Scheme I-2).40   
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Scheme I-2. Alkoxyl radical induced peptide backbone cleavage. 
 
 
Nitrogen-centered radicals 
 
Protein-derived nitrogen-centered radicals can be formed at the backbone 
or at lysine side-chains.39 It has been shown that reaction of proteins with 
hypochlorous acid results in the formation chloroamines which are unstable and 
decomposed to give nitrogen-centered radicals.41 It has also been shown that 
such reactions can lead to protein backbone cleavage; however the mechanisms 
of such processes are not well understood. There is evidence that nitrogen-
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centered radicals can undergo rearrangements to form carbon-centered radicals. 
For example, lysine side-chain aminyl radicals undergo intramolecular hydrogen 
abstraction to form carbon-centered radicals.39 This process is analogous to the 
Hoffman-Löffler-Freytag reaction in organic synthesis.42, 43The Hofmann-Löffler-
Freytag reaction is known to be initiated by the formation of a chloroammonium 
salt from an N-chloroamine in the presence of acid (Scheme I-3). Then by 
irradiation or heat, this salt is converted to a nitrogen radical cation. Hydrogen 
atom abstraction by the nitrogen radical cation at C-5 results in a carbon 
centered radical which is then captured by a chlorine radical. The 1,5-hydrogen 
abstraction is favored by the stability of a six-member ring transition state. Ionic 
cyclization follows to form pyrrolidine derivatives. 
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Scheme I-3. Mechanism of the Hoffmann-Löffler-Freytag reaction. 
 
 
Research Goals 
 
Radical degradation of proteins has received a great amount of attention 
in the context of disease. However, the application of radical processes to 
proteomics has yet to be explored. The work presented here involves the 
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investigation of the radical induced backbone cleavage of peptides and proteins 
and its application to the improvement of top-down proteomics methodologies.  
Our research efforts are aimed at the following: 
1. The development of a gas-phase peptide fragmentation strategy based on 
backbone cleavage induced by lysine side-chain nitrogen-centered 
radicals. This technique has the potential to facilitate fragmentation of 
intact proteins by mass spectrometry methods. 
2. The development of a mass spectrometry technique for identification of 
the N-terminal amino acid of peptides, based on radical induced amino 
acid side chain cleavage.  Applications of this technique include 
improvement of peptide mass fingerprinting methods and de novo 
sequencing strategies.  
3. The investigation of chemical-based methods of fragmentation of large 
proteins to improve top-down methodologies. 
 
References 
 
1. Liebler, Daniel C., Introduction to Proteomics: Tools for the New Biology. 
Humana Press: Totowa, NJ, 2002; 198. 
2. Reid, G. E.; Mcluckey, S. A. "'Top Down' Protein Characterization Via 
Tandem Mass Spectrometry."Journal of Mass Spectrometry 2002, 37, 
663-675. 
3. Walker, J. M., The Protein Protocols Handbook. 2nd. Humana Press Inc.: 
Totowa, NJ, 2002; 1146. 
4. Gevaert, K.; Vandekerckhove, J. "Protein Identification Methods in 
Proteomics."Electrophoresis 2000, 21, (6), 1145-1154. 
 23
5. Westermeier, R; Naven, T., Proteomics in Practice. Wiley-VCH Verlag-
GmbH: Weinheim, 2002; 316. 
6. Swanson, S. K.; Washburn, M. P. "The Continuing Evolution of Shotgun 
Proteomics."Drug Discovery Today 2005, 10, (10), 719-725. 
7. Ye, M. L.; Jiang, X. G.; Feng, S.; Tian, R. J.; Zou, H. F. "Advances in 
Chromatographic Techniques and Methods in Shotgun Proteome 
Analysis."Trac-Trends in Analytical Chemistry 2007, 26, (1), 80-84. 
8. Washburn, M. P.; Wolters, D.; Yates, J. R. "Large-Scale Analysis of the 
Yeast Proteome by Multidimensional Protein Identification 
Technology."Nature Biotechnology 2001, 19, (3), 242-247. 
9. Wolters, D. A.; Washburn, M. P.; Yates, J. R. "An Automated 
Multidimensional Protein Identification Technology for Shotgun 
Proteomics."Analytical Chemistry 2001, 73, (23), 5683-5690. 
10. Gaskell, S. J. "Electrospray: Principles and Practice."Journal of Mass 
Spectrometry 1997, 62, 677-688. 
11. Downard, K., Mass Spectrometry. The Royal Society of Chemistry: 
Cambridge, UK, 2004; 210. 
12. Aebersold, R.; Goodlett, D. R. "Mass Spectrometry in 
Proteomics."Chemical Reviews 2001, 101, (2), 269-295. 
13. Aebersold, R.; Mann, M. "Mass Spectrometry-Based Proteomics."Nature 
2003, 422, (6928), 198-207. 
14. Weinmann, W.; Stoertzel, M.; Vogt, S.; Svoboda, M.; Schreiber, A. 
"Tuning Compounds for Electrospray Ionization/in-Source Collision-
Induced Dissociation and Mass Spectra Library Searching."Journal of 
Mass Spectrometry 2001, 36, (9), 1013-1023. 
15. March, R. E. "An Introduction to Quadrupole Ion Trap Mass 
Spectrometry."Journal of Mass Spectrometry 1997, 32, (4), 351-369. 
 24
16. Beavis, R. C.; Chait, B. T. "High Accuracy Molecular Weight Determination 
Using Matrix-Assisted Laser Desorption Mass Spectrometry."Analytical 
Chemistry 1990, 62, 1836-1840. 
17. Chait, B. T.; Beavis, R. C. "Laser Desorption Mass-Spectrometry of 
Biomolecules."Abstracts of Papers of the American Chemical Society 
1990, 200, 139-Anyl. 
18. Thiede, B.; Hohenwarter, W.; Krah, A.; Mattow, J.; Schmid, M.; Schmidt, 
F.; Jungblut, P. R. "Peptide Mass Fingerprinting."Methods 2005, 35, (3), 
237-247. 
19. Domon, B.; Aebersold, R. "Review - Mass Spectrometry and Protein 
Analysis."Science 2006, 312, (5771), 212-217. 
20. Taylor, J. A.; Johnson, R. S. "Implementation and Uses of Automated De 
Novo Peptide Sequencing by Tandem Mass Spectrometry."Analytical 
Chemistry 2001, 73, (11), 2594-2604. 
21. Zhang, Z.; Schaffer, A. A.; Miller, W.; Madden, T. L.; Lipman, D. J.; 
Koonin, E. V.; Altschul, S. F. "Protein Sequence Similarity Searches Using 
Patterns as Seeds."Nucleic Acids Research 1998, 26, (17), 3986-3990. 
22. Yates, J. R.; Eng, J. K.; Mccormack, A. L.; Schieltz, D. "Method to 
Correlate Tandem Mass-Spectra of Modified Peptides to Amino-Acid-
Sequences in the Protein Database."Analytical Chemistry 1995, 67, (8), 
1426-1436. 
23. Reinders, J.; Lewandrowski, U.; Moebius, J.; Wagner, Y.; Sickmann, A. 
"Challenges in Mass Spectrometry-Based Proteomics."Proteomics 2004, 
4, 3686-3703. 
24. Gygi, S. P.; Aebersold, R. "Mass Spectrometry and Proteomics."Current 
Opinion in Chemical Biology 2000, 4, (5), 489-494. 
25. Hansen, B. T.; Jones, J. A.; Mason, D. E.; Liebler, D. C. "Salsa: A Pattern 
Recognition Algorithm to Detect Electrophile-Adducted Peptides by 
Automated Evaluation of Cid Spectra in Lc-Ms-Ms Analyses."Analytical 
Chemistry 2001, 73, 1676-1683. 
 25
26. Hansen, B. T.; Davey, S. W.; Ham, A. J. L.; Liebler, D. C. "P-Mod: An 
Algorithm and Software to Map Modifications to Peptide Sequences Using 
Tandem Ms Data."Journal of Proteome Research 2005, 4, 358-368. 
27. Reid, G. E.; McLuckey, S. A. "'Top Down' Protein Characterization Via 
Tandem Mass Spectrometry."Journal of Mass Spectrometry 2002, 37, (7), 
663-675. 
28. Kelleher, N. L. "Top-Down Proteomics."Analytical Chemistry 2004, 76, 
(11), 196a-203a. 
29. Loo, J. A.; Edmonds, C. G.; Smith, R. D. "Primary Sequence Information 
from Intact Proteins by Electrospray Ionization Tandem Mass-
Spectrometry."Science 1990, 248, (4952), 201-204. 
30. Bogdanov, B.; Smith, R. D. "Proteomics by Fticr Mass Spectrometry: Top 
Down and Bottom Up."Mass Spectrometry Reviews 2005, 24, (2), 168-
200. 
31. Cooper, H. J.; Hakansson, K.; Marshall, A. G. "The Role of Electron 
Capture Dissociation in Biomolecular Analysis."Mass Spectrometry 
Reviews 2005, 24, (2), 201-222. 
32. Reid, G. E.; McLuckey, S. A. "'Top Down' Protein Characterization Via 
Tandem Mass Spectrometry."Journal of Mass Spectrometry 2002, 37, 
663-675. 
33. VerBerkmoes, N. C.; Bundy, J. L.; Hauser, L.; Asano, K. G.; 
Razumovskaya, J.; Larimer, F.; Hettich, R. L.; Stephenson, J. L. 
"Integrating "Top-Down" and "Bottom-up" Mass Spectrometric Approaches 
for Proteomic Analysis of Shewanella Oneidensis."Journal of Proteome 
Research 2002, 1, (3), 239-252. 
34. Wehr, T. "Top-Down Versus Bottom-up Approaches in Proteomics."Lc Gc 
North America 2006, 24, (9), 1004. 
35. Fossey, J., Lefort, D., Sorba, J., Free Radicals in Organic Chemistry. John 
Wiley & Sons Ltd: Masson, Paris, 1995; 307. 
 26
36. Yin, H. Y.; Hachey, D. L.; Porter, N. A. "Analysis of Diacyl Peroxides by 
Ag+ Coordination Ionspray Tandem Mass Spectrometry: Free Radical 
Pathways of Complex Decomposition."Journal of the American Society for 
Mass Spectrometry 2001, 12, (4), 449-455. 
37. Yin, H. Y.; Hachey, D. L.; Porter, N. A. "Structural Analysis of Diacyl 
Peroxides by Electrospray Tandem Mass Spectrometry with Ammonium 
Acetate: Bond Homolysis of Peroxide-Ammonium and Peroxide-Proton 
Adducts."Rapid Communications in Mass Spectrometry 2000, 14, (14), 
1248-1254. 
38. Bourgeois, M. J.; Campagnole, M.; Filliatre, C.; Maillard, B.; Manigand, C.; 
Villenave, J. J. "Tert-Butyl Percarbamate and Its N-Alkyl, N,N-Dialkyl and 
N-Azacyclanic Derivatives - Preparation and Thermolysis in 
Solution."Tetrahedron 1982, 38, (24), 3569-3577. 
39. Hawkins, C. L.; Davies, M. J. "Generation and Propagation of Radical 
Reactions on Proteins."Biochimica Et Biophysica Acta-Bioenergetics 
2001, 1504, (2-3), 196-219. 
40. Headlam, H. A.; Mortimer, A.; Easton, C. J.; Davies, M. J. "Beta-Scission 
of C-3 (Beta-Carbon) Alkoxyl Radicals on Peptides and Proteins: A Novel 
Pathway Which Results in the Formation of Alpha-Carbon Radicals and 
the Loss of Amino Acid Side Chains."Chemical Research in Toxicology 
2000, 13, (11), 1087-1095. 
41. Hawkins, C. L.; Davies, M. J. "Hypochlorite-Induced Damage to Proteins: 
Formation of Nitrogen-Centred Radicals from Lysine Residues and Their 
Role in Protein Fragmentation."Biochemical Journal 1998, 332, 617-625. 
42. Majetich, G. "Remote Intramolecular Free-Radical Functionalizations - an 
Update."Tetrahedron 1995, 51, (26), 7095-7129. 
43. Wolff, M. E. "Cyclization of N-Halogenated Amines."Chemical Reviews 
1963, 63, 55-64. 
 
 
 
 
 
 
 27
CHAPTER II 
 
FREE RADICAL-PROMOTED PEPTIDE CLEAVAGE VIA LYSINE 
PEROXYCARBAMATES 
 
Introduction 
 
 Because bottom-up proteomics strategies require long multi-step sample 
purification and analysis, and because of the potential advantages offered by top-
down methods, it would be desirable to improve top-down strategies. Despite all 
the advances in mass spectrometry, in particular the development and 
improvement of FT-ICR instruments, fragmentation of intact proteins remains 
challenging.1-3  Moreover, access to FT-ICR technology is limited to a small 
number of research laboratories due to the high cost of purchase and 
maintenance of the instruments. Therefore mass spectrometry techniques that 
facilitate gas-phase fragmentation of proteins are very valuable for the 
improvement of top-down approaches.  
 Radical reactions of proteins have been shown to result in protein 
degradation by radical induced backbone cleavage.4-6 Nitrogen-centered radicals 
of lysine side-chains have been shown to induce protein backbone cleavage 
possibly via intramolecular hydrogen abstraction to form carbon-centered 
radicals. Precedent for this mechanism can be found in the Hoffman-Löffler-
Freytag reaction, where an aminyl radical cation undergoes 1,5 hydrogen 
abstraction to form a carbon-centered radical (Scheme II-1).  
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Scheme II-1. Mechanism for the Hoffman-Löffler-Freytag reaction. 
 
  Based on this knowledge, the idea of gas-phase protein backbone 
cleavage promoted by nitrogen-centered radicals seems feasible. This could be 
the basis for a mass-spectrometry sequencing technique that offers the 
possibility of intact protein fragmentation without the need for prior enzymatic 
digestion. The chemistry would involve the introduction of a labile covalent bond 
to generate peptide or protein radical species that would facilitate fragmentation. 
Former laboratory members (Dr. Douglas Masterson and Dr. Huiyong Yin) 
pioneered this idea by the use of the chemical modification of lysine residues as 
peroxycarbamates.7 These adducts undergo dissociation under ESI-CID and well 
as MALDI conditions. The result is a lysine aminyl radical that can initiate a 
fragmentation pathway in the gas-phase to produce peptide backbone cleavage 
in the form of a-, b-, c-, and z-type ions.7, 8 These backbone fragments can be 
used to obtain peptide sequence information.   
The lysine peroxycarbamates are obtained by reaction of a lysine 
containing peptide or protein with 4-nitrophenyl-t-butylperoxycarbonate. The 
resulting lysine peroxycarbamates contain a labile O-O bond which is cleaved by 
the CID process. Loss of CO2 then leads to the formation of the aminyl radical.  
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Subsequent local and remote hydrogen abstraction followed by β-scission give 
rise to peptide and side chain cleavage (Scheme II-2).  
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Scheme II-2. Modification of lysine model as a peroxycarbamate and fragmentation by CID. 
 
 
 
Work by other researchers proceeded with the study of other free-radical 
fragmentation pathways initiated by dissociation of labile groups. Hodyss et al. 
reported on work in which the N-terminus of peptides was modified with a free 
radical initiator reagent containing an azo linkage. 9  Dissociation of the azo bond 
after CID lead to a- and z-type ions similar to those formed by electron capture 
dissociation (Scheme II-3).  Hao and coworkers studied the effect of NO 
modification of cysteine and tryptophan residues on peptide fragmentation.10  
They found that dissociation of the S-NO and N-NO bonds resulted in thiyl and 
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aminyl radicals that promoted peptide cleavage products different from those 
found by CID of unmodified peptides (Scheme II-4). 
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Scheme II-3.  CID fragmentation of peptides modified at the N-terminus with an azo radical 
initiator. 
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Scheme II-4. CID fragmentation of N- and S-nitroso peptides. 
 
The development of low-energy based fragmentation techniques has the 
potential to be useful in assisting fragmentation of intact proteins by mass 
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spectrometry without the need of prior enzymatic digestion. Therefore such 
methods would be very valuable in the improvement of top-down proteomics 
approaches. 
 
Results and Discussion 
 
Model Lysine Peroxycarbamate Studies7 
Studies on the fragmentation of a model lysine peroxycarbamate by ESI-
CID were carried out by Masterson and Yin. Modification the model lysine (N-α-
acetyl lysine methyl ester) to the corresponding peroxycarbamate was carried out 
by reaction with the reagent II-2 (4-nitrophenyl-t-butyl-peroxycarbonate) under 
basic conditions (1:1 0.1M NH4CO3/acetonitrile, pH 8.6) as shown in Scheme II-
5.  The immediate formation of a yellow solution indicated the release of 4-
nitrophenolate from the reaction.   
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Scheme II-5. Peroxycarbamate modification of model lysine. 
 
To investigate the fragmentation of this model lysine peroxycarbamate, it 
was subjected to CID using an ESI-triple-quadrupole instrument.  Fragmentation 
of the lithium adduct of II-3 at low CID energy off-sets (< 20 eV) produced mainly 
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a fragment which correspond to the loss of the t-BuOOC(O)-  and is attributed to 
an aminyl radical (Scheme II-6).  As the CID voltage was increased, a series of 
other smaller fragments were observed. The fragments II-5-8 are emphasized as 
they are the product of chain loss and backbone cleavage.  A plot of the effect of 
CID energy off-set on product ion intensities is shown in Figure II-1. Along with 
the appearance of these smaller fragments, there was a decrease in the intensity 
of the aminyl radical ion II-4 with increased CID off-set energy, which suggested 
this to be an intermediate.  None of these fragments were observed when the 
unmodified N-α-acetyl-lysine methyl ester lithium adduct was subjected to CID.    
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Scheme II-6. CID fragmentation of model lysine peroxycarbamate. 
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Figure II-1. CID of the lithium adduct of II-3. Effect of increasing CID off-set voltage on intensity of 
product ions. 
 
 
Mechanism of Fragmentation of Model Lysine Peroxycarbamate8 
 Based on the preliminary studies by Masterson and Yin  discussed in the 
previous section, ESI-CID experiments were carried out in order to confirm the 
aminyl radical as an intermediate in the side chain and backbone cleavage 
pathways. An in-source CID experiment was performed on the model lysine 
peroxycarbamate II-3 lithium adduct (m/z =325). With increased tube lens 
voltages (> 90 V) we were able to observe the aminyl radical II-4 in the full Q1 
scan at m/z = 208, and selected this ion for CID. The resulting product ion 
spectrum showed ions like those observed in the CID spectrum of the parent 
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peroxycarbamate adduct II-3 at m/z = 325 (Figure II-2).  As the CID off-set 
voltage was increased, there was an increase in the intensity of side chain and 
backbone cleavage products and a decrease in the intensity of the parent ion II-4 
(Figure II-3). These results suggest that fragments II-5-8 are indeed products of 
the decomposition of II-4. 
The formation of the aminyl radical II-4 is the result of homolytic cleavage 
of the O-O bond followed by decarboxylation, a reaction known to occur with 
diacyl peroxides and peroxycabamates.11-13  The aminyl radical intermediate may 
undergo several radical rearrangement pathways that lead to side chain and 
backbone fragmentation giving products II-5-8 as well as other other fragments 
(Scheme II-7). Hydrogen abstraction by the aminyl radical II-4 can occur on the 
lysine side chain or backbone.  A 1,5 hydrogen shift, through a six-member ring 
transition state,  followed by β-scission, leads to fragments II-7, and II-9. This 
process is well-known in the Hofmann-Löffler-Freytag reaction.14, 15 The1,5 
hydrogen shift may be followed by a 1,2 hydrogen shift and β-scission to give 
side chain fragment II-6.  The aminyl radical II-4 may also undergo 1, 4 hydrogen 
shift through a 5-member ring trasition state to give II-8 
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Figure II-2. A) ESI-CID spectrum of  the lysine peroxycarbamate model II-3 (m/z = 325). B) ESI-
CID spectrum of aminyl radical II-4 (m/z = 208) formed by in-source CID of II-3. All species are 
lithium adducts. 
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Figure II-3. A) In-source CID of the lithium adduct of II-3 (m/z = 325), effect of tube lens voltage 
on the intensity of product ions. B) CID of aminyl radical II-4 (m/z = 208) produced by in-source 
CID of lithiated II-3, effect of CID off-set voltage on product ion intensities. 
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Other fragmentation pathways can compete with the formation of the 
aminyl radical.  For example, incomplete decomposition of the t-butyl peroxy 
group of parent II-3 and recombination of the aminyl radical with an alkoxyl 
radical, leads to product ions II-11-13.  The formation of these fragments is 
suported by studies on a deuterated lysine peroxycarbamate model containing 
the moiety (CD3)3OOC(O)-. It was found that fragment II-13 contained the 
(CD3)3O- moiety. In addition,  a deuterium was found in fragments II-11 and II-12, 
indicating involvment of the t-butyl group in the formation of these compounds. 
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Scheme II-7. Proposed mechanism of fragmentation of model lysine peroxycarbamate II-3 (m/z = 
325). 
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Peptide Peroxycarbamate Studies7, 8 
Peptides containing one or more lysines were modified with the 
peroxycarbonate reagent II-2.  Singly, doubly, and up to multiply modified 
peptide-peroxycarbamate adducts were observed by ESI-MS depending on the 
number of lysines present in the peptide. The peptide Ac-GSAKVSF protected at 
the N-terminus by an acetyl group, was modified at the free lysine side chain as a 
t-butyl peroxycarbamate. The ESI-MS spectrum of the lithium adduct showed 
peaks corresponding to unreacted peptide m/z = 859.3 (M + Li+) and a lysine 
peroxycarbamate adduct m/z = 875.3 (M + 116 + Li+).  CID on this adduct gave 
the daughter ions shown in Scheme II-8.   These ions were not observed in the 
CID spectrum of the unmodified peptide. These fragments are similar to the CID 
products derived from the model lysine peroxycarbamate; however, other 
backbone cleavage fragments of the type a, b, and c were also observed.  
Replacing Li+ with other counter ions such as Na+ and Ag+ gave similar results.  
CID of the protonated adduct did not lead to the expected daughter ions, 
possibly due to the hydrophobicity of the peptide.  However, more polar peptides 
(containing multiple lysines) showed typical fragmentation patterns with all 
counter ions including H+. Multiply-modified peptides showed fragments in the 
CID spectra corresponding to the loss of each t-BuOOC(O)- group, as well as 
side chain and peptide cleavage fragments derived from each lysine aminyl 
radical. 
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Scheme II-8. CID fragments of modified Ac-GSAKVSF where lysine was converted to the 
respective t-butyl peroxycarbamate (m/z 875.3, M+116 + Li+). 
  
      
 The radical process leading to peptide fragmentation in these studies can 
be correlated with the mechanism of peptide fragmentation by Electron Capture 
Dissociation (ECD).16 A comparison of the mechanism of radical-promoted 
peptide fragmentation by aminyl radicals produced from lysine peroxycarbamates 
and by ECD is shown in Scheme II-9. In ECD, electron capture by a positively 
charged amino acid leads to a backbone carbon-centered radical, which then 
results in side chain and backbone cleavage with c-, and z-ions being 
predominant. ECD has been successfully used in top-down FT-ICR proteomics 
studies of intact proteins due to the higher sequence coverage obtained 
compared to CID. 
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Scheme II-9. A) Proposed mechanism of radical-promoted peptide fragmentation by lysine 
aminyl radicals produced from lysine peroxycarbamates. B) Proposed mechanism of radical-
promoted peptide fragmentation by ECD. 
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 MALDI experiments on peptide peroxycarbamates also produced 
backbone fragmentation initiated by loss of the t-BuOOC(O)- group. The intact 
peptide peroxycarbamate adducts were not observed since they do not survive 
the laser desorption process. Instead, decomposition of the t-BuOOC(O)- group 
occurs at the source and only fragments derived from this process are detected. 
As an example, the MALDI spectrum of the modified peptide Ac-
SYMEHFRWGKPVGKKR (a mixture of 1, 2, and 3 peroxycarbamate 
modifications) is shown in Figure II-4. Fragments were detected corresponding to 
backbone fragmentation at each of the lysine residues. In addition, the sequence 
of the fragments was confirmed by MS/MS analysis. 
 All of these peptide studies suggest that radical-promoted gas-phase 
fragmentation of proteins is feasible; however, protein studies face some 
limitations. First, the presence of multiple lysine modifications on large peptides 
or proteins results in complex CID spectra, which is a challenge in fragment 
characterization. In addition, when modified small proteins such as Ribonuclease 
A are subjected to ESI-CID or MALDI analysis, fragmentation is not clearly 
detected. In the case of ESI-MS analysis, because the ions are distributed along 
multiple charge states, only a small population of the protein is represented in a 
particular charge state. When the protein is modified with II-2, there is also a 
distribution of multiple lysine peroxycarbamate adducts in each charge state, 
which means an even smaller amount of protein is represented in a single ion. 
Therefore when selecting a single adduct ion for CID, the product ions will have 
very low intensities. 
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Figure II-4. A) MALDI spectrum of unmodified peptide Ac-SYMEHFRWGKPVGKKR. B) MALDI 
spectrum of modified peptide as a mixture of 1, 2, and 3 lysine peroxycarbamate adducts. a11, Ac-
SYMEHFRWGK*, a15, Ac-SYMEHFRWGKPVGK*, a16, Ac-SYMEHFRWGKPVGKK* 
(modifiecations represented by the asterisk). C) MS/MS spectrum of ion a11 from spectrum A. 
 
 
  In the case of MALDI analysis of modified ribonuclease A, a broad peak 
near the m/z of the unmodified protein was observed, possibly due to metastable 
ion decay. In order to improve ESI-CID spectra, it is necessary to concentrate the 
protein population to fewer ions.  This can be achieved by reducing the extent of 
lysine modification, therefore obtaining fewer peroxycarbamate adducts. In 
addition, fewer adducts would improve the resolution of the MALDI spectra.  The 
peroxycarbonate reagent II-2 is very reactive towards the amino group of the 
lysine side-chain, therefore when modifying peptides or proteins with this reagent 
most or all lysines will be converted to their peroxycarbamates. In order to control 
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the extent of lysine modification, less reactive reagents and milder reaction 
conditions are necessary.  
 
Synthesis of Other Peroxycarbonate Reagents 
In order to control the extent of lysine modification in peptides and 
proteins, we synthesized other less reactive peroxycarbonate reagents than II-2. 
These less reactive reagents differ from II-2 in that the nitro group is replaced by 
an alkoxyl group (ethylene glycol). The reaction of the lysine ε-amino group and 
II-2 is a nucleophilic acyl substitution17, and the reactivity of II-2 will be greatly 
affected by the nature of the phenyl substituent group.  In II-2, the nitro group has 
an electron withdrawing effect, making the acyl carbonyl electron deficient and 
therefore more susceptible to nucleophilic attack. The nitro group also stabilizes 
the phenolate leaving group through resonance, making this a better leaving 
group. The alkoxy group has an electron donating effect, making the acyl 
carbonyl electron rich, and the phenolate a worse leaving group, which slows 
down the rate of nucleophilic attack. The synthesis of these less reactive 
reagents is shown in Scheme II-10.  The peroxycarbonates II-16 and II-17 were 
synthesized by the reaction of the phenols II-14 and II-15 with phosgene, 
followed by reaction with t-butyl hydroperoxide in the presence of pyridine. 
Synthesis of the phenol II-14 involved the alkylation of acetophenone with 1-
bromo-2-methoxy-ethane in the presence of potassium carbonate, followed by a 
Baeyer-Villiger oxidation and acid hydolysis.18, 19 The synthesis was also 
attempted by alkylation of hydroquinone with 1-bromo-2-methoxy-ethane under 
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basic conditions;20, 21 however this method was not successful possibly due to 
quenching of the reaction by air oxidation of hydroquinone. Synthesis of the 
phenol II-15 was carried out by alkylation of resorcinol with 1-bromo-2-methoxy-
ethane in the same manner as the alkylation of acetophenone; however, an 
excess of resorcinol was necessary in order to minimize dialkylation.  
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Scheme II-10. Synthesis of peroxycarbonate reagents. 
 
 
Peptide modifications with II-16 and II-17 
The reagents II-16 and II-17 were used to modify peptides with 2 or more 
lysines and study the extent of modification achieved with these compounds. The 
peptides used for these experiments were the 7-mer AcGKASVKF (777.4 Da )   
and the 17-mer SYSMEHFRWGKPVGKKR (2093.4 Da). The peptides were 
modified in 1:1 NH4HCO3/acetonitrile and using different amounts of reagent. A 
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mass spectrum (ESI-Q1 scan) was obtained for each reaction mixture and the 
relative peak intensities for the different peroxycarbamate adducts were plotted 
against the amount of reagent used (Figure II-5 and Figure II-6). With both 
reagents II-16 and II-17, it is feasible to obtain a significant amount of singly 
modified peptides while keeping multiply adducts at relatively low levels. 
However, reaction times with these reagents are longer than with II-2.  The 
reagent II-16 required overnight incubation, and II-17 two-hour incubation, 
whereas reactions with II-2 only required a few minutes.  
 
Figure II-7 illustrates the high reactivity of II-2 towards lysine modification 
compared to II-16 and II-17. When the 17-mer was modified with II-2, multiple 
lysine sites were modified with very low amounts reagent.  In addition, all 4 
amine sites on the peptide were modified, whereas with II-16, and II-17 only 3 
modifications were detected.  
 
 In summary, these experiments show that reagents II-16 and II-17 are less 
reactive than II-2. Therefore we can limit the number of lysines modified by using 
these reagents.  This may be useful in the characterization of CID spectra of 
modified peptides containing a large number of lysine residues. The extent of 
lysine modification can then be varied in a systematic way to determine patterns 
of fragmentation.  Reagent II-17 may be more useful in these studies since II-16 
requires overnight incubation.  Nevertheless, different reagents may suit different  
systems being studied.  
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Figure II-5. Amount of reagent versus extent of lysine modification for peptide AcGKASVKF. A) 
Modification of petide with II-16.  B) Modification of peptide with II-17.  Relative abundances 
include all charge states present in the spectrum for a given adduct. Molar equivalents of 
reagents were calculated based on moles of peptide used. 
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Figure II-6. Amount of reagent versus extent of lysine modification for peptide 
SYSMEHFRTWGKPVGKKR . A) Modification with II-16. B) Modification with II-17.  Relative 
abundances include all charge states present in the spectra for a given adduct. Molar equivalents 
of reagents were calculated based on moles of peptide used. 
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Figure II-7. Amount of 4-nitrophenyl- t-butyl peroxycarbonate (II-2) versus extent of modification 
for peptide SYSMEHFRWGKPVGKKR. Relative abundances include all charge states for a given 
peroxycarbamate adduct. Molar equivalents are calculated based on moles of peptide used. 
 
 
Lysine Peroxycarbamates of Ribonuclease A 
 The protein ribonuclease A (13682 Da) was modified with reagent II-2.  
Modification of this protein resulted in a mixture of multiple peroxycarbamate 
adducts. The protein contains 11 lysines, and all lysine side chains and the N-
terminus amine are prone to modification.  When the modified protein mixture 
was analyzed by ESI-MS, up to 10 peroxycarbamate adducts were observed.  
CID experiments on these adducts did not lead to detectable product ions.  The 
ribonuclease A peroxycarbamate adducts were also studied by MALDI.  As 
mentioned above in the peptide peroxycarbamate studies, intact 
peroxycarbamate adducts are not detected in MALDI due to their decomposition 
during the laser desorption process. Instead, in the case of peptide 
peroxycarbamates, only the fragments derived from loss of the t-BuOOC(O)- 
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group are seen. In the case of ribonuclease A, the spectrum of the modified 
protein showed a broad peak around the m/z of the unmodified protein.  
However, no fragments derived from peroxycarbamate decomposition were 
observed.  In order to simplify our analyses of the protein peroxycarbamates, and 
improve the MALDI spectrum resolution, we reduced the extent of lysine 
modification by adjusting the reaction conditions. We first attempted the 
modification of ribonuclease A with reagents II-16 and II-17; however, the longer 
reaction times necessary for significant modification to take place, lead to 
degradation of the protein.  Therefore, we limited our studies to modifications 
with II-2, and reduced the amount of reagent used from 140 molar equivalents of 
reagent to 2-10 molar equivalents. Figure II-8 shows a comparison of the extent 
of modification of ribonuclease A with 140 and 10 molar equivalents of reagent.  
The portion of the ESI-MS spectrum containing the peroxycarbamate adducts in 
the 10+ charge state is shown. From these spectra it is evident that we are able 
to obtain mostly singly and doubly modified protein by lowering the amount of 
reagent used.  We note however, that the lower extent of lysine modification is 
accompanied by a significant amount of unreacted protein.  
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Figure II-8. ESI-MS spectrum of modified ribonuclease A showing the 10H+ charge state.  The 
numbers in blue represent the number of peroxycarbamate modifications.  A) Modification using 
10 molar equivalents of reagent II-2.  B) Modification using 140 molar equivalents of reagent II-2. 
 
 
 To further simplify MS studies of these protein adducts, we isolated the 
protein containing 1 and 2 peroxycarbamate adducts by cation-exchange 
chromatography. The cation-exchange chromatogram of the protein 
peroxycarbamate mixture is shown in  
Figure II-9. Several peaks were observed for singly and doubly modified protein, 
which is possibly due to modification at different lysine positions. Fractions were 
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collected from this run and analyzed by ESI-LC-MS. Figure II-10 shows the LC 
and MS spectrum for a single fraction containing singly modified protein.   
 
 
0 mod1 mod2 mod
 
 
Figure II-9. Cation-exchange chromatogram of modified Ribonuclease A. Fractions were 
collected every minute for MS analysis. 
 
  
 ESI-CID and MALDI analyses of these isolated protein peroxycarbamate 
fractions however did not lead to protein fragmentation.  In ESI-triple quadrupole 
and ion trap analyses, although we were successful in isolating ribonuclease A 
containing only 1 or 2 peroxycarbamate modifications, the fractions obtained 
from cation-excange chromatography may still contain a mixture of regioisomers. 
These regioisomers arise from the adduction of 1 peroxycarbamate at different 
lysine positions on the protein. CID of this mixture of regioisomers would result in 
a different set of fragments ions for each regioisomer. These fragments would 
also be multiply charged, therefore a single fragment ion in the CID spectrum 
 52
would represent a very small percentage of the total ion population, thus 
remaining undetectable in the experiment. A schematic of this process is shown 
in Figure II-11. 
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Figure II-10. LC-MS analysis of singly modified ribonuclease A obtained from cation-exchange 
separation.  A) LC chromatogram showing singly modified ribonuclease at 19.24 min. B) MS 
spectrum under the LC peak at 19.24 min. Numbers in red represent different charge states. 
 
   
 In the case of MALDI we know from peptide peroxycarbamate studies that 
fragmentation of the lysine peroxycarbamates occurs at the source.  When singly 
modified or doubly modified ribonuclease A is subjected to MALDI, the spectrum 
shows a single instense peak with m/z equal to that of the unmodified protein. It 
is possible that this peak corresponds to a mixture of lysine aminyl radicals 
corresponding to different regioisomers. However, no further fragmentation is 
observed. 
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Figure II-11. Illustration of the formation of regioisomers of ribonuclease A due to 1 
peroxycarbamate modification. Each regioisomer gives rise to different fragments and each 
fragment may be multiply charged. 
 
 
Conclusion 
 
 The modification of lysine as a peroxycarbamate can induce site-specific 
peptide cleavage in the gas-phase by ESI-CID or MALDI.  This fragmentation 
occurs by a radical mechanism initiated by homolysis of the O-O bond, followed 
by decarboxylation. The aminyl radical produced in this process undergoes 
radical rearrangements which lead to backbone and side chain fragments.  
These backbone fragments are of the type a, b, c, and z, and may be useful in 
peptide sequencing. Although our preliminary studies on protein 
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peroxycarbamates have not yet been successful, further studies utilizing more 
advanced mass spectrometers such as an FT-ICR may offer more insight in the 
utility of this strategy for top-down approaches. 
  
Experimental Procedures 
 
General 
 The model lysine (N-α-acetyl lysine methyl ester) was purchased from 
Aldrich Chemical Co. (Milwaukee, WI, USA) in its hydrochloride salt form.  
Peptides were purchased from American Peptide Co. (Sunnyvale, CA, USA).  
Ribonuclease A was obtained from Sigma (Milwaukee, WI, USA). All other 
reagents were purchased form Aldrich Chemical Co. Solvents were HPLC grade, 
purchased from Fisher Scientific (Pittsburgh PA, USA) t-Butyl-4-nitrophenyl-
peroxycarbonate was synthesized according to previous work in our laboratory.7   
The NH4CO3 buffer system used for lysine peroxycarbamate modifications 
consisted of a 1:1 mixture of 0.1 M NH4CO3 (pH 8.6) and acetonitrile.  For cation-
exchange chromatography, a carboxymethyl column (Hydrocell CM 1500, 150 x 
4.6 mm) was used, purchased from BioChrom Labs, Inc. (Terre Haute, IN, USA). 
Cation-exchange analysis was carried out on a Waters HPLC system (Milford, 
MA, USA).  LC-MS analysis were done using a C18 column (10 cm x 1 mm x 
5um), from Grace Vydac (Hesperia, CA, USA). NMR spectra were acquired on a 
Bruker Advance 300 MHz instrument. HRMS was carried out at Ohio State 
University (Columbus, OH, USA). 
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Peroxycarbamate Modifications 
 Modification of the model lysine II-1 was carried out by combining 5 μl of 
the amino acid stock solution (0.1M in  1:1 acetonitrile/water) with 20 μl of 
NH4CO3 buffer system, and 20 μl of II-2 (0.1 M in acetonitrile). The final 
concentrations for the model lysine and reagent II-2 were 0.01 M and 0.04 M 
respectively. Reactions were incubated at room temperature for 15 minutes. 
Modification of peptides was carried out in a similar manner by combining 10 μl 
of peptide stock solution in water (1 mg/ml), 20 μl of NH4CO3 buffer system,  and 
10 μl of reagent II-2 solution (0.1 M in acetonitrile). The molar ratio of reagent to 
peptide was approximately 100:1.  For reagent reactivity studies with II-2, II-16, 
and II-17, the amount of reagent was adjusted to ratios from 1:1 to 30:1 reagent 
to peptide.  For II-16, the modification reactions were allowed to incubate 
overnight at room temperature. For II-17, two-hour incubation times were 
sufficient to obtain enough modified peptide for MS analysis. 
 
Ribonuclease A Modifications 
 Modification of ribonuclease A to obtain multiple peroxycarbamate adducts 
was carried out by combining 100 μl of the protein stock solution (10μg/ml in 
water) with 100 μl of NH4CO3 buffer system and 100 μl of reagent II-2 stock 
solution (0.1 M in acetonitrile). The molar ratio of reagent to protein was 
approximately 140:1.  To reduce the number of peroxycarbamate modification, 
the amount of reagent was reduced to a ratio of 10:1 reagent to protein. Cation- 
exchange chromatography separation of the modified protein adducts was done 
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according to an altered literature procedure.22 For the separation, an HPLC 
method was used with a commercially available cation-exchange column (see 
general section).  The elution solvents consisted of A: 95% water, 5% methanol; 
B: 95% 0.16 M NH4PO4, 5% methanol. The elution gradient was 0% to 20% 
solvent B into solvent A in 60 minutes, at a flow rate of 1ml/min. Fractions were 
collected using an automated Waters (Milford, MA, USA) fraction collector every 
1 min. with a 15 min. start delay.  The fractions were reduced to 200 μl under 
vacuum for LC/MS analysis. 
 
Synthesis of Peroxycarbonate Reagents 
 
Synthesis of 4-nitrophenyl-t-butylperoxycarbonate (II-2)7 
 A 50 ml round bottom flask was charged with 20 ml of methylene chloride 
and 2.0g (9.9 mmoles) of 4-nitrophenyl chloroformate. The solution was cooled to 
0oC and 1 eq. of t-butyl hydroperoxide was added in decane in one portion. The 
resulting solution was stirred and 1 eq. of anhydrous pyridine was added drop 
wise over 10 minutes. The solution was allowed to warm to room temperature 
and stirred for an additional hour. The resulting solution was then diluted with 50 
ml of methylene chloride and washed 2X with 1% H2SO4, 1X with brine, and 
dried over MgSO4. The solution was then concentrated and purified by silica gel 
column chromatography with 1:1 hexane/ether to provide 1.0g of pure product as 
a white solid (3.9 mmoles, 39%). 1H-NMR (300 MHz, CDCl3): 1.40 (s, 9H), 7.41 
(d, 2H, j=9.3 Hz), 8.29 (d, 2H, j=9.3 Hz). 13C-NMR (75 MHz, CDCl3): 25.9, 85.3, 
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121.5, 125.4, 145.6, 151.8, 155.0. HRMS = 278.0635 (M+Na+) calculated. 
278.0638 observed.  
 
Synthesis of peroxycarbonate reagents II-16 and II-17 
4-(2-methoxy-ethoxy)-acetophenone 19   
 The compounds 4-Hydroxy-acetophenone (4.00 g, 29.4 mmol), 1-bromo-
2-methoxy-ethane (4.89 g, 35.1 mmol), and potassium carbonate (5.80 g, 35.1 
mmol), were added to 50 ml of anhydrous DMF. The reaction was allowed to stir 
overnight at the solvent reflux temperature in a nitrogen atmosphere. The 
reaction mixture was cooled to room temperature, water was added (50 ml) and 
the solution was extracted with ether (3 x 50 ml). The combined ether extract was 
washed with water (2 x 10 ml) and dried over MgSO4. Evaporation of the solvent 
left a caramel color paste (4.14 g, 73 % yield). 1H NMR (300 MHz, CDCl3): δ 2.53 
(s, 3H), 3.44 (s, 3H), 3.75-3.78 (m, 2H), 4.16-4.19 (m, 2H), 6.90-6.98 (m, 2H), 
7.88-7.94 (m, 2H). 13C NMR (300 MHz, CDCl3): δ26.27, 59.19, 67.38, 70.70, 
114.16, 130.41, 130.47, 162.60, 196.69.  HRMS (M+Na+) 217.083513 calculated, 
217.08371 observed. 
4-(2-methoxy-ethoxy)-acetoxy- benzoate18 
To a solution of 4-(2-methoxy-ethoxy)-acetophenone (3.68g, 18.6 mmol) 
in chloroform (60 ml), was added m-chloroperbenzoic acid (6.4g, 37.2 mmol) and 
p-toluenesulfonic acid (60 mg, 1.6 %). The reaction was allowed to stir overnight 
at room temperature. The mixture was filtered and the mother liquor was washed 
with 0.1 M pH 7.4 phosphate buffer (4 x 60 ml). The organic layer was washed 
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with water (2 x 20 ml) and dried over MgSO4. The solvent was evaporated 
leaving a yellow-orange paste. The crude product was redissolved in a minimum 
amount of chloroform (10 ml) and passed through a silica plug (1:1 ether/ 
hexane). Removal of solvent resulted in a cream color solid (3.26g, 83 % yield). 
1H NMR (300 MHz, CDCl3): δ 2.27 (s, 3H), 3.43 (s, 3H), 3.72-3.75 (m, 2H), 4.08-
4.28 (m, 2H), 6.89-7.0 (m, 4H). 13C NMR (300 MHz, CDCl3): δ21.00, 59.14, 
67.61, 70.92, 115.15, 122.22, 144.29, 156.38, 169.79.  
4-(2-methoxy-ethoxy)-phenol (II-14) 18  
A solution of 4-(2-methoxy-ethoxy)-acetoxy-benzoate (2.75g, 13.0 mmol) 
in acetone (80 ml) and 4 M HCl (15 ml) was heated to solvent reflux temperature 
(60 oC ) overnight under nitrogen. The acetone was removed in vacuo and the 
aqueous residue was extracted with ether (3 x 50 ml). The combined ether 
extract was washed with water (2 x 10 ml) and dried over MgSO4. The ether was 
removed in vacuo leaving an off-white solid (2.08 g, 90 % yield). 1H NMR (300 
MHz, CDCl3): δ 3.47 (s, 3H), 3.72-3.75 (m, 2H), 4.04-4.07 (m, 2H), 6.72-6.81 (m, 
4H). 13C NMR (300 MHz, CDCl3): δ  59.16, 67.89, 71.16, 115.76, 115.99, 149.80, 
152.78. HRMS (M+Na+) 233.078428 calculated, 233.07925 observed.  
3-(2-methoxy-ethoxy)-phenol (II-15)18  
Resorcinol (2.4g, 21.6 mmol) was added to 20 ml of anhydrous DMF. To 
this mixture, K2CO3 (1.8 g, 10.8 mmol) was added, followed by slow addition of 1-
bromo-2-methoxy-ethane (1 ml, 10.8 mmol). The reaction mixture was allowed to 
stir at the solvent reflux temperature, overnight, under nitrogen. The mixture was 
cooled to room temperature, diluted with 20 ml of water and extracted with ether 
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(3 x 15 ml). The combined ether extract was washed with water (5 ml) and dried 
over MgSO4. The solvent was evaporated in vacuo and the crude liquid was 
purified by silica-gel column chromatography (10 % methanol in chloroform) 
yielding a light yellow solid (1g, 54 % yield). 1H NMR (300 MHz, CDCl3): δ 3.44 
(s, 3H), 3.73-77 (m, 2H), 4.07-4.10 (m, 2H), 6.51-6.54 (m, 3H), 7.12-7.19 (m, 
1H). 13C NMR (300 MHz, CDCl3): δ59.13, 67.13, 70.92, 101.64, 107.04, 129.72, 
159.86. 
4-(2-methoxy-ethoxy)-phenyl-t-butylperoxycarbonate (II-16) and 3-(2-
methoxy-ethoxy)-phenyl-t-butylperoxycarbonate (II-17)  
 
Diisoprophylethylamine (2.20 ml, 12.4 mmol) was added slowly to a 
solution of the phenol (II-14, 2.08g, 12.4 mmol, or II-15, 2.7g, 16.0 mmol) in 
methylene chloride. The resulting solution was added very slowly to a cold (0 oC) 
1.93 M phosgene solution in toluene (13 ml, 25 mmol). The reaction mixture was 
allowed to reach room temperature and stirred overnight under nitrogen. The 
excess phosgene was removed by purging with a moderate stream of dry 
nitrogen and adding solvent as needed for 1 ½ hours. The solvent was 
evaporated in vacuo and the crude product was used without purification. The 
crude chloroformate was redissolved in 40 ml of methylene chloride and cooled 
to 0 oC. A 5 to 6 M solution of t-butyl-hydroperoxide in dodecane (2.4 ml, 12 
mmol) was added, followed by drop-wise addition of pyridine (1 ml, 12.4 mmol). 
The reaction mixture was allowed to stir overnight at room temperature, under 
nitrogen. The solvent was evaporated and the product purified by silica gel 
column chromatography (30 % ethyl acetate in hexane) as a light yellow solid II-
15, 65 % yield) and a clear liquid (II-16,  64 % yield). 1H NMR II-16 (300 MHz, 
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CDCl3): δ 1.37 (s, 9H), 3.45 (s, 3H), 3.71-3.74 (m, 2H), 4.07-4.10 (m, 2H), 6.89-
6.93 (m, 2H), 7.06-7.11 (m, 2H). II-17 δ1.36  (s, 9H), 3.43  (s, 3H), 3.72-3.75 (m, 
2H),  4.08-4.12  (m, 2H), 6.78-6.85 (m, 3H), 7.27-7.30 (m, 1H).13C NMR (300 
MHz, CDCl3): II-16 δ 25.88, 59.12, 67.62, 70.85, 84.59, 115.23, 121.52, 144.44, 
153.30, 156.72. II-17 δ 25.74, 59.10, 67.40, 70.66, 84.60, 107.37, 112.66, 
112.94, 129.83, 151.42, 152.72, 159.55. For II-16 HRMS (M+Na+) 307.11520 
calculated, 307.11618 observed.   
 
Mass Spectrometry 
 Mass spectrometry analyses of the model lysine peroxycarbamate and 
peptides were performed on a TheromoFinnigan (San Jose, CA, USA) TSQ 7000 
triple-quadrupole instrument, equipped with an ESI source. The capillary 
temperature was kept at 200 oC, and the voltage was 20V. The electrospray 
needle voltage was 4.5 kV, and the tube-lens voltage was maintained between 
70 and 100 V. The sheath and auxiliary gases (N2) were adjusted to maximize 
signal. The off-set voltage in CID experiments was generally between 20 and 30 
eV. Samples were introduced into the source for direct infusion experiments 
either as lithiated (LiCl) or protonated solutions (acetic or formic acid). For in-
source CID studies of the model lysine peroxycarbamate, the tube-lens voltage 
was varied from 20 to 120 V. For CID mechanism studies, the off-set voltage was 
varied from 5 to 35 eV. LC/MS analysis of ribonuclease A peroxycarbamate 
adducts was carried out on a ThermoFinnigan (San Jose, CA, USA) LCQ Deca 
XP ion-trap instrument, equipped with an ESI source, and a HP Agilent (Palo 
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Alto, CA, USA) HPLC system. Instrument parameters were tuned using 
angiotensin II peptide as a standard to maximize signal. MALDI analyses were 
carried out for ribonuclease A on an Applied Biosystems (Foster City, CA, USA) 
Voyager DE STR instrument. For peptides, MALDI analyses were done with an 
Applied Biosystems (Foster City, CA, USA) 4700 Proteomics instrument, 
equipped with a TOF-TOF mass analyzer. Matrices consisted of α-cyano-4-
hydroxycinnamic acid for peptides and 3,5 Dimethoxy-4-hydroxycinnamic acid  
for ribonuclease A (10 mg/ml in 4:6 0.1 % TFA/acetonitrile). Samples were 
spotted on a gold target plate (0.5 μl sample and 0.5 μl matrix solution).   
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CHAPTER III 
 
N-TERMINAL AMINO ACID SIDE CHAIN CLEAVAGE OF CHEMICALLY 
MODIFIED PEPTIDES IN THE GAS PHASE 
 
 
Introduction 
The rapid development and improvement of mass spectrometry, along 
with the availability of large genome databases, have made possible high-
throughput characterization of complex protein mixtures.1 Nevertheless, the 
presence of unexpected post-translational modifications often leads to 
unsuccessful or incorrect identifications in database searches. In addition, the 
study of proteins derived from organisms whose genomes are not complete is 
limited.2 In such cases, more labor-intensive data analysis such as de novo 
sequencing must be used, where the peptide sequence is reconstructed from the 
MS/MS fragmentation data with the help of sequencing algorithms.3-5 Due to the 
complexity of peptide MS/MS spectra, a number of methods have been 
developed to facilitate interpretation. N-terminal and C-terminal charged 
derivatives were developed in the late 1980’s to be used with Fast Atom 
Bombardment (FAB) analyses in order to simplify fragmentation spectra 
produced from high energy collision induced dissociation (CID). In addition, these 
charged derivatives were useful in increasing  signal intensity of peptide fragment 
ions in such experiments.6, 7  Keough and coworkers derivatized the N-termini of 
peptides with a sulfonic acid group.8, 9 Fragmentation of these peptides by CID 
and Postsource Decay (PSD) Matrix-Assisted Laser Desorption Ionization 
(MALDI), yielded selectively the y-ion series. Work by Geskell et al. investigated  
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N-terminus derivatization using phenylthiocarbamoyl derivatives similar to those 
employed in Edman degradation.10 CID experiments in this case produced 
predominantly b1 and yn-1 ions. James and coworkers carried out the modification 
of N-termini of peptides with nicotinyl-N-hydroxysuccinimide which resulted in 
suppression of the y-ion series in MALDI tandem time of flight (MALDI-TOF-TOF) 
analyses.11  More recently, Reilly and co-workers investigated the effect of 
acetaminidation of N-termini on fragmentation patterns in CID spectra.12 In most 
cases studied, there was an enhancement of yn-1 ions while diminishing other 
fragmentations, and in some cases contiguous series of b-NH3 ions were 
observed.  Another approach to improving de novo methods involves stable 
isotopic labeling. Esterification of C-termini with deuterium labeled methanol 
results in a mass shift of the y-ions with respect to the unlabeled peptide ester 
thus identifying the y-ion series.13 In a similar manner, O18 labeling of C-termini 
provides information about the y-ion series. 14  Cannon and coworkers presented 
a computational method to obtain information from the natural isotopic 
distributions of peptide fragments in MS/MS spectra, in order to facilitate 
identification of b- and y-ions without prior derivatization.15 
In the work described in this chapter, we have utilized the 
peroxycarbamate chemistry discussed in chapter II to develop a mass 
spectrometry based N-terminus identification technique.  The conversion of the 
N-terminal α-amino group of amino acids and peptides to a peroxycarbamate 
adduct, leads to CID fragmentation involving cleavage of the N-terminal amino 
acid side chain (Scheme III-1). This fragmentation provides information about the 
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nature of the N-terminal residue and may also serve as a labeling technique for 
elucidating the b-ion series in de novo analyses.  
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Scheme III-1. Fragmentation of N-terminal peroxycarbamates by CID. 
 
 
Results and Discussion 
The chemistry of peroxycarbamates is based on previous work from our 
laboratory on the derivatization of  lysine residues as discussed in chapter II.16, 17 
The mechanism for the fragmentation of lysine peroxycarbamates is thought to 
be initiated by the dissociation of the t-butyl peroxy group to form an aminyl 
radical intermediate, followed by remote hydrogen abstraction and β-
fragmentation of the resulting carbon radicals (Scheme III-2).  Introduction of the 
labile peroxide bond provides a low-energy fragmentation pathway to free 
radicals that ultimately affect the peptide fragmentation patterns. More recently, 
Beauchamp and coworkers18 made use of reagents that modified peptide N-
termini with an azo functional group.  Decomposition of the labile azo linkage led 
to a protocol they dubbed “Free Radical Initiated Peptide Sequencing (FRIPS)” 
where a- and z-type fragments are obtained by CID instead of the typical b- and 
y-type ions (Scheme III-3). 
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Scheme III-2. Modification of lysine model as a peroxycarbamate and fragmentation by CID. 
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Scheme III-3. CID fragmentation of peptides modified at the N-terminus with an azo radical 
initiator. 
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Based on Lysine peroxycarbamate chemistry, we investigated the effect of 
modification of the N-terminus as a peroxycarbamate on fragmentation patterns 
upon CID.  Amino acids and peptides modified at the N-terminus as 
peroxycarbamates, and subjected to CID, lead to the cleavage of the N-terminal 
amino acid side chains (Scheme III-4). This fragmentation allowed the 
identification of the N-terminal residue and led the way to a mass spectrometry 
based N-terminus identification technique.19 
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Scheme III-4. Peroxycarbamate modification of N-termini and CID fragmentation. 
 
N-Terminal amino acid side-chain loss 
A series of amino acids and peptides were modified at the N-terminus with 
reagents III-1a-1c to form N-terminal peroxycarbamates. The amino acids were 
ester derivatives in the form NH2CH(R)CO2R’ (M) where R is the amino acid side 
chain, and R’ is either a methyl, ethyl or a t-butyl group and were converted to 
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the peroxycarbamates C4H9OOC(O)NHCH(R)CO2R’ (C4H9OOC(O)M) .  ESI-CID 
analysis of the lithium adducts of these derivatives lead to fragmentation 
involving the loss of the t-butyl peroxide group (C4H8OOC(O), m/z = 116), to give 
a product ion with m/z equal to the underivatized amino acid ester M 
[C4H9OOC(O)M – 116] , and another product ion which corresponds to the imine 
NH=CHCOOR’, or [M - (R+1)] with m/z equal to the loss of the t-butyl peroxide, 1 
hydrogen, and the amino acid side chain,  [C4H9OOC(O)M – 117 – R] (Scheme 
III-5).  A sample CID spectrum of modified valine methyl ester is shown in Figure 
III-1. Lithium was used as the counter ion for CID of the modified amino acids 
due to the unavailability of the N-terminus for protonation. Cleavage of the amino 
acid side chain was not observed in the CID spectra of unmodified amino acids. 
In most cases [C4H9OOC(O)M – 116] was the predominant fragment for the 
modified compounds, this suggests that gas phase decomposition of the t-
butylperoxy group is an important process; however, the imine fragment was 
present in most spectra. A list of modified amino acids and corresponding CID 
fragmentations are presented in Table III-1. 
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Scheme III-5. CID fragmentation of N-terminal peroxyacarbamate amino acid ester derivatives. 
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Figure III-1. CID spectrum of N-terminal peroxycarbamate valine methyl ester. 
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Table III-1.  N-terminal peroxycarbamates amino acid adducts and their CID fragmentation. 
Amino 
Acida 
[M + Li+] 
m/z 
[tBuOOC(O)M + Li+]
m/z 
Neutral
Lossb 
R R 
m/z 
Gly 96.1 212.0 117.0 H 1 
Ala 110.1 226.1 132.0 CH3 15 
Val 138.0 254.2 160.1 CH(CH3)2 43 
Leu 152.1 268.2 174.1 CH2CH(CH3)2 57 
Ile 152.2 268.2 174.2 CH(CH3)CH2CH3 57 
Glu 210.0 326.0 204.1 (CH2)2(CO)OC2H5 101 
Asp 168.0 283.9 190.0 CH2(CO)OCH3 73 
Asn 194.4 311.1 ------- CH2(CO)NH2 58 
His 176.1 291.9 198.0 CH2C3H3N2 81 
Met 170.1 285.9 192.1 (CH2)2SCH3 75 
Phe 186.0 302.0 208.1 CH2C6H5 91 
Ser 126.0 242.0 148.1 CH2OH 31 
Tyr 202.1 318.0 224.1 CH2C6H5O 107 
Trp 225.0 341.0 247.0 CH2C8H6N 130 
Thr 140.2 256.1 162.1 CH(OH)CH3 46 
Gln 208.3 325.1 189.0 (CH2)2(CO)NH2 72 
Lys 181.1 297.2 189.0 (CH2)4NH2 72 
Proc 137.0 251.9 ------- C3H7 43 
Cysd ------- ------- ------- CH2SH 47 
Arg 189.0(H+) 305.0 217 (CH2)3NHC(NH2)2 100 
 
 a Amino acids are methyl esters derivatives (M = NH2CH(R)CO2CH3) with the exception of Asp 
and Glu which are the dimethyl ester and diethyl ester derivatives respectively, Lys is the ethyl 
ester and Gln and Asn are the t-butyl ester derivatives. b Neutral loss corresponds to 117 + R  
where 117 is the m/z of the C4H9OOC(O) group + 1 hydrogen and R is the amino acid side chain. 
c Cleavage of the side chain was not observed for Pro, only loss of the C4H9OOC(O) group was 
seen. d The MS spectrum of modified Cys was complex and did not contain a peak corresponding 
to [C4H9OOC(O)M], suggesting decomposition of the amino acid may occur during the 
modification reaction. Modified Asn was also an exception where no side-chain loss was 
observed. 
 
 An imine ion was not observed for modified Cys and Pro. In the case of 
Cys the peroxycarbamate adduct was not observed in the Q1 spectrum. This 
adduct may not form or may not be stable due to the reactive thiol group nearby. 
The observation that Met does not present this problem supports the hypothesis 
of the interfering effect of the free thiol group.  In most cases in “real” proteomics 
analyses, Cys residues will be alkylated (e.g., with iodoacetamide) to produce S-
carboxamido derivatives. These, similarly to methionine, will likely be better 
behaved than a free Cys in the peroxycarbamate reaction. In the case of 
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modified Pro, the N-terminus is part of a five-member ring structure, which may 
prevent side chain cleavage. Modified Gly did not appear to yield N-terminal loss 
of the side chain hydrogen by CID, but instead, a fragment consistent with the 
m/z of the N-terminal aminyl radical was observed [C4H9OOC(O)M – 117].  Asn 
also does not undergo side chain cleavage for reasons not well understood; 
however, this was not the case for peptides containing Asn at the N-terminus, as 
will be discussed in the next section. 
 
Peptide modifications   
In order to selectively modify peptides at the N-terminus and not at lysine, 
the pH and reagent were varied (a list of modified peptides and their 
corresponding fragmentation is shown in Table III-1) which was modified under 
different pH conditions, ranging from 5.2 to 8.6.  In this way the pH optimum for 
N-terminal modification over ε-amino modification of Lys could be established.  
Previous studies have shown that selectivity for reactions at the N-terminal α-
amino group of peptides can be achieved by pH control.20-23 Lowering the pH 
below the pKa of the terminal α−amino group (approximate pKa = 8) increases 
the selectivity for reaction at the N-terminus with respect to the ε-amino group of 
lysine (approximate pKa = 10.7). In addition to pH control, a less reactive reagent 
than III-1a (III-1b) offers higher selectivity for reaction at the N-terminus (Scheme 
III-1).  
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Figure III-2. Peroxycarbonate reagents. 
 
Reagent III-1b is less reactive towards nucleophilic attack by the amine 
nitrogen than III-1a, therefore modification occurs at a slower rate with this 
reagent. The reaction can be accelerated by increasing the temperature to 37 oC, 
conditions under which reagent III-1a undergoes decomposition. LC/MS analysis 
of the modified peptide revealed that under basic conditions (pH 7.5 to 8.5) and 
with reagent III-1a, modification occurs at both amino group sites, but with 
greater efficiency on the lysine side chain. Slightly acidic conditions (pH 5.5) and 
reagent III-1b gave better selectivity for the N-terminus.  Figure III-3 shows the 
LC/MS trace of the modified peptide for reactions carried out at pH 8.6 and 5.5. 
Peak 1 in the chromatogram corresponds to m/z = 758.2 ([M+3H] +3) where M = 
YRVRFLAKENVTQDAEDNC. Peaks 2 and 3 indicate a single modification with 
m/z = 796.8 ([C4H9OOC(O)M + 3H] 3+).  Peak 2 corresponds to modification at 
the N-terminal group, whereas peak 3 corresponds to ε-amino modification of 
lysine. This was confirmed by the CID fragmentation of peak 2, also shown in 
Figure III-3, where the ion with m/z = 722.2 ([C4H9OOC(O)M – 117 – 107+ 3H]3+) 
indicates the neutral loss of  C4H9OOC(O) and the N- terminal tyrosine side chain 
(-CH2-C6H4OH, m/z = 107). This fragment was absent in the CID spectrum of 
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peak 3. At lower pH and with the use of reagent III-1b, peak 3 is diminished, 
which implies a preference for N-terminal modification under these conditions.    
Several peptides containing different N-terminal amino acids were modified using 
reagent III-1b at pH 5.5 and the N-temini were identified in CID experiments 
(Table III-2). Thus, CID spectra of peptide peroxycarbamates bearing alanines at 
the N-terminus give product ions that indicate the loss of the side chain -CH3 
([C4H9OOC(O)M - 117-15]), whereas terminal valines show a similar loss of the 
side chain -CH3CHCH3 and so on. In cases where Cys and Pro were the terminal 
residues (entries 18 and 20 in Table III-2), the CID spectra did not lead to an 
imine fragment. As seen for the model amino acids, N-terminal Cys did not give a 
peroxycarbamate adduct, due to interference by the free thiol group, and the CID 
spectrum of N-terminal proline-peroxycarbamate only showed an [C4H9OOC(O)M 
– 116] ion and no side chain cleavage. Nevertheless, the presence of these 
amino acids anywhere else in the sequence did not affect the fragmentation 
chemistry at the N-terminus of modified peptides. CID of a modified peptide 
bearing glycine at the N-terminus (entry 9 in Table III-2) yielded similar 
fragmentation to the CID of the modified model amino acid, where the N-terminal 
aminyl radical [C4H9OOC(O)M – 117] was observed instead of the expected 
imine fragment [C4H9OOC(O)M – 117 – 1].  Results from the CID of a modified 
peptide bearing Asn at the N-terminus (entry 5 in Table III-2) indicated loss of the 
Asn side-chain, which is in contrast to results obtained with the modified Asn 
amino acid derivative. 
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NH=CHC(O)RVRFLAKENVTQDAEDNC (3H+) 
D m/z = 722 
Figure III-3. LC/MS of modified peptide YRVRFLAKENVTQDAEDNC. (A) Selected Ion 
Monitoring (SIM) m/z = 758.2 ([M+3H] +3) where M is the unmodified peptide 
YRVRFLAKENVTQDAEDNC. (B) SIM m/z = 796.8 ([C4H9OOC(O)M + 3H] +3) where M was 
modified with reagent III-1b at pH 5.5. Peaks 2 and 3 correspond to N-terminus and lysine 
modifications, respectively. (C) SIM m/z = 796.8 ([C4H9OOC(O)M + 3H] +3) where M was modified 
with reagent 1a at pH 8.6. (D) CID spectrum of peak 2, parent m/z = 796.8 ([C4H9OOC(O)M +3H] 
3+). The product ion m/z = 722.2 corresponds to the loss of C4H9OOC(O) and  the N-terminal 
Tyrosine side chain, CH2C6H4OH ([C4H9OOC(O)M – 117 – 107 + 3H] 3+). 
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Table III-2. CID fragmentation of N-terminal peroxycarbmates of peptides. 
 
 
Entry Sequence Ma 
m/z 
[C4H9OOC(O)M]b 
m/z 
Imine 
Fragment c 
m/z 
R R 
m/z 
1 VYIHPF 775.4(1H+) 891.5(1H+) 731.1(1H+) CH(CH3)2 43 
2 HPKRPWIL 523.4(2H+) 581.8(2H+) 483.1(2H+) CH2C3H3N2 81 
3 MEHFRW 962.0(1H+) 1078.0(1H+) 887.2(1H+) (CH2)2SCH3 75 
4 SRVSRRSR 335.2(3H+) 373.8(3H+) 324.5(3H+) CH2OH 31 
5 NRVYVHPF 516.4(2H+) 574.4(2H+) 486.9(2H+) CH2(CO)NH2 58 
6 FHPKRPWIL 597.4(2H+) 655.4(2H+) 551.9(2H+) CH2C6H5 91 
7 KNPYIL 768.4(1Na+) 885.2(1Na+) 679.7(1Na+) (CH2)4NH2 72 
9 GFLRRI 761.4(1H+) 877.5(1H+) 760.3(1H+) H 1 
10 WHWLQL 882.5(1H+) 998.5(1H+) 752.1(1H+) CH2C8H6N 130 
11 QRPRLSHKGPMPF 518.0(3H+) 556.4(3H+) 592.6(3H+) (CH2)2(CO)NH2 72 
12 LSRLFDNAl 468.5(2H+) 526.5(2H+) 877.7(1H+) CH2CH(CH3)2 57 
13 ISRPPGFSPFR 630.9(2H+) 689.0(2H+) 602.0(2H+) CH(CH3)CH2CH3 57 
14 EDKDLD 795.2(1Na+) 911.5(1Na+) 722.0(1Na+) (CH2)2(CO)OH 73 
15 YGSLPQKSQRSQDEN 868.6 (2H+) 926.8(2H+) 815.11(2H+) CH2C6H4OH 107 
16 TPRK 251.1(2H+) 308.9(2H+) 205.8(2H+) CH(OH)CH3 46 
17 APRLRFYSL 561.9(2H+) 619.8 (2H+) 553.1(2H+) CH3 15 
18 PPGFSPFR 904.3(1H+) 1020.4(1H+) ------------- C3H7 43 
19 RPKPQQF 900.3(1H+) 1016.5(1H+) 801.2(1H+) (CH2)3NHC(NH2)2 100 
20 CNLAVAAASHIYQNQFQ 660.1(3H+) -------------- ------------- CH2SH 47 
21 YRVRFLAKENVTQDEDC 758.2(3H+) 796.8(3H+) 722.2(3H+) CH2C6H4OH 107 
22 DRVYIHPF 523.5(2H+) 582.1(2H+) 493.8(2H+) CH2(CO)OH 59 
a m/z of unmodified peptide. b m/z of peptide modified with reagent III-1b at pH 5.5. c 
[C4H9OOC(O)M – 117 – R] fragment or imine fragment in CID spectrum resulting from the 
neutral loss of the C4H9OOC(O) group +1 hydrogen (117) and the N-terminal amino acid side 
chain (R). 
 
 When a mixture of the two isobaric peptides HPKRPWIL and DRVYIHPF 
(entries 2 and 22 in Table III-2) was modified at pH 5.5 using reagent III-1b, the 
two peptides were distinguishable in LC-MS selected reaction monitoring (SRM) 
and neutral loss experiments by N-terminal side-chain cleavage (Figure III-4).  
Thus, the peptide bearing an N-terminal histidine can be distinguished from the 
peptide bearing aspartic acid without further sequencing. Figure III-4(B) shows 
the SRM of m/z = 582 ([C4H9OOC(O)M + 2H] 2+) Æ m/z = 483 ([C4H9OOC(O)M – 
117- 81 + 2H] 2+) where M is  HPKRPWIL and the side chain of histidine (CH2-
C3H3N2)  has  m/z = 81. Figure 3(C) shows the SRM of m/z = 582 
([C4H9OOC(O)M + 2H] 2+) Æ m/z = 494 ([C4H9OOC(O)-M – 117- 59 + 2H] 2+) 
where M is DRVYIHPF and the side chain of aspartic acid (-CH2COOH) has m/z 
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= 59. These results illustrate the use of N-terminal side chain loss as a quick 
diagnostic peptide identification method without the need for a complete 
sequencing experiment. This technique may be valuable in peptide mass 
fingerprinting studies, where N-terminus identification can be used to eliminate 
false positive matches in database searching.24 
 
 
A 
B 
C 
 
Figure III-4.  LC-SRM trace of peptide mixture HPKRPWIL and DRVYIHPF modified with reagent 
III-1b at pH 5.5. (A) SIM m/z = 582 ([C4H9OOC(O)M + 2H] 2+) where M is either peptide. (B) SRM 
of m/z = 582 ([C4H9OOC(O)M + 2H] 2+) Æ m/z = 483 ([C4H9OOC(O)M – 117- 81 + 2H] 2+) where 
M is  HPKRPWIL, and the histidine side chain (CH2-C3H3N2) has m/z = 81. (C) SRM of m/z = 581 
([C4H9OOC(O)M – 117- 81 + 2H] 2+) Æ m/z = 494 ([C4H9OOC(O)M – 117- 59 + 2H] 2+)where M is 
DRVYIHPF and the aspartic acid side chain (-CH2COOH) has  m/z = 59.  
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Mechanism of N-terminal Side Chain Cleavage 
CID spectra of N-terminal peroxycarbamate adducts of amino acids and 
peptides showed fragments with m/z  equal to the m/z of the unmodified species 
[C4H9OOC(O)M – 116] derived from  decomposition of the C4H9OOC(O) and 
addition of a hydrogen. In most cases this fragment [C4H9OOC(O)M – 116] is 
predominant and it is accompanied by another fragment corresponding to an 
imine derived from the neutral loss of the N-terminal amino acid side chain 
[C4H9OOC(O)M – 117 – R]. In order to determine whether the two fragments are 
part of the same radical decomposition pathway, we carried out an in-source CID 
experiment using an ESI-triple quadrupole instrument to obtain the ion 
[C4H9OOC(O)M – 117 – R] in Q1 and isolate it for further CID.  The CID 
spectrum of this ion did not generate an imine ion [C4H9OOC(O)M – 117 – R], 
Instead the spectrum was comparable to that obtained for the unmodified 
species. This suggests that the [C4H9OOC(O)M – 116] fragment can not be an 
intermediate in the side chain loss, [C4H9OOC(O)M – 117 – R].  Two 
mechanisms must be in play, with one leading to formation of M from 
C4H9OOC(O)M and the other giving side chain cleavage (Scheme III-6). 
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Scheme III-6. A) Fragmentation of N-terminal peroxycarbamates by CID. B) CID of the 
[C4H9OOC(O)M – 116] fragment obtained by in-source CID of N-terminal peroxycarbmates.   
 
 It is unclear how the peroxycarbamate adducts decompose by CID to 
provide the unmodified peptide or amino acid and to address this question we 
prepared compound III-2 shown in Scheme III-7.  Based on CID studies with a 
model lysine peroxycarbamate containing the moiety C4H9-d9OOC(O) (See 
chapter II), we suspected that the t-butyl group of the peroxycarbamate would be 
a possible source of an H atom during the CID process leading to the peptide or 
amino acid fragment, [C4H9OOC(O)M] Æ M. Compound III-2 was prepared from 
the commercially available 2-bromo-2-methylpropane-d9 by reaction with 
anhydrous hydrogen peroxide in the presence of silver triflate.25 The resulting 
hydroperoxide was treated with 3-nitrophenyl chloroformate providing III-2 (See 
experimental section).  
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Scheme III-7. Preparation of deuterated peroxycarbonate reagent. 
 
Compound III-2 was then used to modify the N-terminus of the peptide 
WHWLQL (entry 10 in Table III-2) using conditions for selective N-terminus 
modification. The deuterium labeled peroxycarbamate C4H9-d9OOC(O),  III-3 was 
subjected to CID and the resulting product ions included the N-terminal side 
chain loss fragment, and a fragment corresponding to M+1, suggesting that 
deuterium transfer to the peptide attends peroxycarbamate dissociation. This 
indicates that the decomposition of the peroxycarbamate III-3 follows a pathway 
in which a hydrogen (deuterium) atom is transferred from the t-butyl group to the 
α-amino of the N-terminus resulting in a CID fragment identical to the unmodified 
peptide (Scheme III-8). The mechanistic details of this hydrogen (deuterium) 
atom transfer remain unclear, although an intermediate carbamic acid could be 
involved, as could either radical or ion pair species. 
A reasonable mechanism for loss of R, the N-terminal amino acid side 
chain, proceeds through the aminyl radical, which is formed by homolysis of the 
weak O-O bond followed by decarboxylation.  Loss of R by β-fragmentation of the 
aminyl radical appears to be mechanistically reasonable based on studies on 
lysine peroxycarbamates. 
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Scheme III-8. Proposed mechanism for dissociation of N-terminal peroxycarbamate. 
 
Peroxycarbamate Modification of a Tryptic Digest 
A myoglobin tryptic digest standard was modified using reagent III-1c at 
pH 5.5. Reagent III-1c appeared to provide better conversion to 
peroxycarbamates than either III-1a or III-1b. Reagent III-1c is more reactive 
than III-1a and III-1b, which would suggest that this reagent would not be as 
selective for the N-terminus as reagent III-1b; however, both III-1a, and III-1b 
required longer reaction times at pH 5.5 (over 4 hours). The modification 
reactions described here are pseudo 1st order with rate = kobs[peptide] due to the 
large excess of reagent used.26 Because peptides are present in the digest 
mixture at much lower concentrations (μM) compared to the peptide 
concentrations in the model modification reactions shown in Table III-2 (mM), the 
reaction rate is slower with reagents III-1a and III-1b in this case and a more 
reactive reagent is needed. LC-MS/MS analysis was carried out on the 
unmodified as well as the modified digest. Visual inspection of the MS data 
identified 12 most abundant peptides, 7 of which were modified (Table III-3). 
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Identification of the peptides from MS/MS spectra was confirmed by database 
search algorithm SEQUEST27 and the P-Mod algorithm.28 N-terminal side chain 
cleavage was observed in data-dependent MS2 experiments for entries 2,4,5,7, 
and 8.  MS3 of the imine ion of entry 2 [C4H9OOC(O)M – 117 – R], exhibited a 
labeled b-ion series  indicating the loss of the N-terminal valine side chain + 1 
hydrogen with respect to the unmodified peptide M (mass shift = -44), while the 
y-ion series remained unchanged (Table III-4).  Thus the fragmentation of the N-
terminal side-chain serves to label the b-ion series, which can aid de novo 
sequencing analyses. 
 
Table III-3. Peptides detected by LC-MS from a modified myoglobin digest. 
Entrya Peptide Sequence Unmodified 
m/z 
Modifiedb 
m/z 
Mass  
Shiftc 
1 HLKTEAEMK 371.8 (4H+) -------------- -------------- 
2 ALELFR 374.8 (2H+) 864.3 (1H+) 116 
3 YKELGFQG 472.3 (2H+) -------------- -------------- 
4 LFTGHPETLEK 424.8 (3H+) 694.5 (2H+) 116 
5 HGTVVLTAIGGILK 460.4 (3H+) 748.0 (2H+) 116 
6 HPGDFGADAQGAMTK 752.0 (2H+) 810.0 (2H+) 116 
7 VEAKIAGHGQEVLIR 536.6 (3H+) 862.1 (2H+) 116 
8 GLSDGEWQQVLNVWGK 908.6 (2H+) 966.5 (2H+) 116 
9 GHHEAELKPLAQSHATK 464.5 (4H+) -------------- -------------- 
10 YLEFISDAIIHVLHSK 943.3 (2H+) -------------- -------------- 
11 LFTGHPETLEKFDK 416.2 (4H+) -------------- -------------- 
12 ELGFQG 650.2 (1H+) 766.1 (1H+) 116 
  
aEntries in blue are peptides for which modification at the N-terminus is observed. bm/z  of 
modified peptides ([C4H9OOC(O)M]). cMass shift is adjusted for singly charged species. 
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Table III-4. b- and y-ions from MS2 of unmodified peptide VEAKIAGHGQEVLIR compared to b- 
and y-ions from MS3 of the modified peptide ([C4H9OOC(O)M]). 
  b-ions   y-ions  
Position 
 MS2 
unmodified 
peptidea 
MS3 
modified 
peptideb 
Mass 
shiftc 
MS2 
unmodified 
peptidea 
MS3 
modified 
peptideb 
Mass 
shift 
2 228.79 ------ ------ ------ ------ ------ 
3 299.92 ------ ------ 401.14 401.40 0.26 
4 414.86 371.26 -43.60 500.16 500.45 0.29 
5 528.21 483.72 -44.49 629.14 629.56 0.42 
6 599.25 ------ ------ 757.22 757.54 0.32 
7 656.19 612.14 -44.05 814.34 814.34 0.00 
8 793.06 749.19 -43.87 951.60 951.52 -0.08 
9 850.39 806.07 -44.32 1008.45 1008.49 0.04 
10 978.37 933.46 -44.91 1079.51 1079.59 0.08 
11 1108.16 1063.40 -44.76 1192.67 1192.40 -0.27 
12 1206.36 1162.33 -44.03 1308.66 1307.56 -1.10 
13 1319.99 1276.47 -43.52 1378.14 ------ ------ 
14 1432.56 1388.61 -43.95 ------ ------ ------ 
  
a Parent ion m/z = 804.1 (M + 2H)2+ where M is the peptide VEAKIAGHGQEVLIR. bParent ion 
m/z = 782.1 ([C4H9OOC(O)M – 117- 43 + 2H] 2+), Where valine (-CH(CH3)2) has m/z = 43. cThe 
difference between the b-ions corresponds to the valine side chain +1 hydrogen.  
 
The SALSA algorithm29 was used to search through tandem MS data for 
spectra indicating the N-terminal side-chain losses. The SALSA algorithm was 
designed to find characteristics in the MS/MS spectra such as charged and 
neutral losses, a particular product ion, or a sequence motif. It can also search 
for a combination of two or more of these characteristics and it does not require a 
peptide sequence input. SALSA scores do not indicate the probability of false 
positives, but instead rank spectra based on intensity and number of ions found 
that match a search criteria. We searched our modified myoglobin digest data for 
the neutral loss of 116, which leads to the fragment [C4H9OOC(O)M - 116] or 
simply [M]. This generated a list of precursor ions that match the m/z of peptide-
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peroxycarbamates in the digest mixture. To find peptides bearing a certain amino 
acid at the N-terminus, we added a secondary search characteristic 
corresponding to the neutral loss of 117 + R, which leads to the imine fragment 
[C4H9OOC(O)M– 117 – R] or [M – (R+1)] . Thus, ions corresponding to neutral 
loss of 117 + R were scored only in CID spectra also containing the primary loss 
of 116.  This scoring scheme reduced the number of false positive matches. For 
example, a SALSA search for MS/MS spectra of peptides bearing histidine at the 
N-terminus scored a primary neutral loss of 116 linked to a secondary neutral 
loss of 198 (116 + 1 + 81, where 81 = m/z of His side chain). To improve 
matching accuracy, we also specified doubly charged ions, since these dominate 
the spectra.  The first 6 of 24 results in the SALSA output for this search are 
shown in Table III-5. Given the scoring scheme described above, the highest 
scoring spectra met both the primary and secondary criteria. The top score 
matched the m/z of modified peptide C4H9OOC(O)HGTVVLTALGGILK (entry 2 in 
Table III-5). This result was validated by visual inspection of the MS/MS data. 
Other peptides bearing histidine at the N-terminus (entries 4 and 6) exhibited low 
scores due to lower relative intensity of product ions corresponding to the scored 
losses. The peptide in entry 3 does not contain histidine at the N-terminus; 
however, this precursor ion leads to an intense [C4H9OOC(O)M - 116] product 
ion (neutral loss of 116), therefore it scores higher than entries 4 and 6. It 
addition, this precursor ion also leads to a neutral loss of 198, which is unrelated 
to the N-terminal side chain loss; however, this ion is present in lower intensity. 
Entry 5 has a higher score than entry 6 even though the peptide does not bear 
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histidine at the N-terminus, because this precursor ion also gives an intense 
[C4H9OOC(O)M - 116] product ion; however, it does not match the neutral loss of 
198. Nevertheless, this analysis can be useful in filtering large amount of data in 
order to find peptides of interest.  
 
Table III-5. First 6 results from SALSA search for peptides with histidine at the N-terminus in a 
myoglobin digest. 
 
 
 
 
Entry Score Precursor 
m/z (2H+)a 
Retention 
Time (min) 
Modified Peptide  
(tBuOO(CO)M) 
Loss = 116b Loss = 198c 
1 19.25 747.75 27.01 HGTVVLTALGGILK 689.93 -------- 
2 14.46 748.09 27.13 VVLTALGGILK 689.92  648.71  
3 7 966.63 27.70 GLSDGEWQQVLNVWGK 908.54 867.27  
4 6.11 601.27 22.80 TEAEMK 542.79 502.26  
5 4.56 739.04 27.95 ALELFRNDIAAK 681.11 -------- 
6 4.4 817.95 21.14 GDFGADAQGAMTK 759.87  718.79  
 
 
 
HGT
HLK
HP
a Doubly charged precursor ions which lead to product ions in the MS/MS spectra matching a 
neutral loss of 116 (loss of C4H9OOC(O)) alone or accompanied by the neutral loss of  198 (loss 
of C4H9OOC(O) +1 hydrogen –R of histidine). b Doubly charged product ions corresponding to the 
neutral loss of 116 with respect to the precursor ion. c Doubly charged product ions corresponding 
to the neutral loss of 198 with respect to the precursor ion. 
 
 N-terminal side-chain cleavage by MALDI 
A series of peptides containing each 20 amino acids at the N-terminus 
were modified with conditions selective for N-terminal modification (pH 5.5, 
reagent III-1b). The adducts were analyzed by a MALDI-TOF (Table III-6).  As 
discussed in Chapter II, intact peroxycarbamate adducts are not detected by 
MALDI. The laser desorption process results in dissociation of the t-butyl peroxy 
group at the source. Therefore, only the fragments derived from the adduct 
dissociation are detected.  In the analysis of lysine side-chain peroxycarbamates, 
fragments corresponding to backbone cleavage at each lysine position are 
observed. With N-terminal peroxycarbamates, a fragment with m/z equal to the 
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unmodified peptide is detected, along with a fragment corresponding to the imine 
[C4H9OOC(O)M – 117 – R]. These results are consistent with the ESI studies 
discussed above. In the case of the peptide with the N-terminal glycine, only the 
loss of the C4H9OOC(O)- group was observed, and no imine fragment was 
detected (entry 8 in Table III-6). Peptides with proline and cysteine at the N-
terminus also did not produce an imine fragment (entries 18 and 20 in Table III-
6), as expected based on ESI results.   Examples of MALDI spectra are shown in 
Figure III-5 for entries 4 and 12. The spectra contain ions corresponding to the 
m/z of the intact peptides (M), derived from the loss of the C4H9OOC(O)- group, 
and the corresponding imine ions derived from the cleavage of the N-terminal 
side chain and 1 hydrogen (M – (R + 1)). Thus the m/z difference between the 
two ions identifies the N-terminal side chain.  
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Table III-6. Analysis of modified peptides (N-terminal peroxycarbamates) by MALDI. 
 
Entry Sequence a[M +1H]+ 
 
bImine fragment m/z 
[M – (R + 1) + 1H]+ 
R R 
m/z 
1 VSSNISEDPVPV 1265.3(Na+) 1221.6 (Na+) CH(CH3)2 43 
2 HPKRPWIL 1045.5 965.3 CH2C3H3N2 81 
3 MEHFRW 963.3 887.3 (CH2)2SCH3 75 
4 SRVSRRSR 1004.5 972.5 CH2OH 31 
5 NVIEISNDLENLR 1032.1 972.9 CH2(CO)NH2 58 
6 FHPKRPWIL 1194.7 1102.7 CH2C6H5 91 
7 KNPYIL 748.1 675.2 (CH2)4NH2 72 
8 GFLRRI 1762.3 -------- H 
9 WHWLQL 883.3 752.3 CH2C8H6N 130 
10 QRPRLSHKGPMPF 1551.7 1479.1 (CH2)2(CO)NH2 72 
11 LSRLFDNA 936.4 878.3 CH2CH(CH3)2 57 
12 ISRPPGFSPFR 1261.5 1203.5 CH(CH3)CH2CH3 57 
13 EDKDLD 774.3 700.0 (CH2)2(CO)OH 73 
14 DRVYIHPF 1047.3 987.3 CH2(CO)OH 59 
15 YGSLPQKSQRSQDEN 1736.3 1628.1 CH2C6H4OH 107 
16 TPRK 502.2 456.2 CH(OH)CH3 46 
17 APRLRFYSL 1123.6 1107.6 CH3 15
18 PPGFSPFR 905.3 -------- C3H7 43
19 RPKPQQF 901.4 801.2 (CH2)3NHC(NH2)2 100 
20 CNLAVAAASHIYQNQFVQ -------- -------- CH2SH 47 
1 
 
 
 a m/z of intact peptide ion derived from the dissociation of the C4H9OOC(O)- group, followed by 
hydrogen abstraction. b m/z of imine fragment derived from dissociation of the C4H9OOC(O)- 
group and cleavage of the N-terminal side chain. 
 
Analysis of modified myoglobin digest 
 The modified myoglobin tryptic digest used in the ESI-LC-MS analysis was 
analyzed by MALDI-TOF as a crude mixture. The modified peptides were 
identified by the presence of the intact peptide ion (M) and it’s corresponding 
imine ion (M – (R + 1)).  The MALDI spectrum was complex and interpretation of 
the data in this manner proved to be time-consuming. LC separation prior to 
MALDI analysis led to cleaner spectra; however the lack of data manipulation 
software such as SALSA, compatible with MALDI data, impeded faster 
interpretation. The peptide mixture was also analyzed by MALDI-TOF-TOF to 
obtain sequence information on the imine ions.  MS/MS spectra on the imine ions 
showed an m/z shift on the b-ion series compared to the intact peptide ions. This 
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shift or label was equal to the m/z of the N-terminal side chain + 1H, as seen for 
ESI experiments. The MS/MS spectrum for the imine ion of the peptide 
HGTVVLTALGGILK is shown in Figure III-6. The b-ions are shifted by Δm/z = 82, 
which corresponds to the histidine side chain + 1H.  The y-ions remain the same 
as those for the unmodified peptide, which serves as a fingerprint.  
 
 
Figure III-5. MALDI spectra of modified peptides as N-terminal peroxycarbamates. A) modified 
peptide 4 in Table III-6. B) Modified peptide 12 in Table III-6. [M + 1H]+ corresponds to the loss of 
the  C4H9OOC(O)- group, followed by addition of a hydrogen. [M – (R+1) + 1H]+ corresponds to 
the imine ion derived from loss of the C4H9OOC(O)- group, and N-terminal side chain cleavage.  
 
 Despite the need for manual interpretation of MALDI data, this type of 
analysis has the advantage over ESI in that only singly charged species are 
observed, which facilitates identification of the N-terminal amino acid.  The fact 
that both the imine ion and an ion corresponding to the intact peptide are 
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detected allows for the analysis to be carried out in one run, without the need to 
compare spectra of unmodified and modified peptides.  In addition, because 
dissociation of the peroxycarbamates occurs at the source, b-ion labeling can be 
obtained in a single MS/MS event. Nevertheless, the intact peroxycarbamate 
adducts are not observed, thus distinguishing intact peptide ions derived from 
modified peptides and those from unreacted peptides is a difficult task .  A 
combination of both ESI and MALDI techniques would provide complementary 
information and hence a more complete analysis. 
 
 
Figure III-6. MS/MS MALDI spectrum of the imine ion [M – (R + 1) + 1H]+ of the peptide 
HGTVVLTALGGILK from the modified myoglobin tryptic digest. The b-ion series has an m/z shift 
of  -82 , which corresponds to R + 1 where R is the histidine side chain. 
 
 
 
 
Mass (m/z)
%
 In
te
ns
ity
 
399 504 609 714 819 924
392.2
0
10
20
70
80
90
30
40
50
60
100
867.1096
656.0942
412.2218 679.3962
680.2980626.3544 753.3640487.3191
525.3189 709.3660608.3451430.2635 551.2141 688.3515
(b10 – 82)
(b5 – 82)
y4
y5 (b6 – 82) y6
(b7- 82)
(y7 - NH3)
(b8 - 82 - H2O)
(y8 - H2O)
(b9 – 82)
 90
Conclusion 
Results shown in Figure III-4 illustrate the use of N-terminal side chain 
loss as a quick diagnostic peptide identification method without the need for a 
complete sequencing experiment. These results lead the way to the use of this 
technique in peptide mass fingerprinting studies, where N-terminus identification 
can be used to eliminate false positive matches in database searching.24 
Because MS/MS spectra of unmodified peptides lack information about the N-
terminus (b1 and yn-1 ions),30 identification of N-terminal residues would aid in 
obtaining complete sequences in de novo analyses.  In addition, results in Table 
III-4 demonstrate that gas phase cleavage of the N-terminal side chain by CID, 
labels the N-terminus so that a subsequent CID process (MS3) leads to a mass 
shift in the b-ions when compared to the b-ions from the intact peptide.  This 
mass shift corresponds to the m/z of the N-terminal side chain, and serves to 
elucidate the b-ion series in de novo sequencing. MALDI results correlate well 
with ESI analyses. In MALDI however, fragmentation of the N-terminal 
peroxycarbamates occurs at the source, and the fragmentation products are 
observed in the spectra without an MS/MS experiment. Therefore, a labeled b-
ion series of a particular peptide imine ion can be easily obtained by a single 
MS/MS event using a TOF-TOF mass analyzer.  Peptide mass fingerprinting 
studies are typically done with MALDI, thus these results further support the 
utility of the N-terminus identification technique in such studies.   
 The analysis of a myoglobin tryptic digest by ESI-MS and MALDI 
demonstrates that this N-terminus identification method is feasible in a 
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proteomics setting.  In ESI analyses, data manipulation software such as SALSA 
can be used to sort through large amounts of MS/MS spectra and find peptides 
of interest by N-terminal side chain loss. MALDI analysis can facilitate 
interpretation of the data by providing singly charged species. 
 
Experimental Proceedures 
 
General 
Amino acids were purchased from Aldrich Chemical Co, Inc. (Milwaukee, 
MA) as either methyl, ethyl or t-butyl ester derivatives in their hydrochloride salt 
forms.  Peptides were purchased from American Peptide Company (Sunnyvale, 
CA).  Solvents were HPLC grade, obtained from Fisher Scientific (Pittsburgh, 
PA). All other reagents were purchased from Aldrich Chemical Co, Inc. 
(Milwaukee, MA).  Acetate buffers (10 mM) of various pH values were prepared 
from ammonium acetate titrated to pH 5.2, 5.5, and 5.8 with acetic acid.  Tris 
buffers were 0.1M solutions titrated to pH 7.5 and pH 8 respectively. Ammonium 
bicarbonate buffer was a 0.1 M solution at pH 8.6. Buffer systems used to modify 
peptides and amino acids consisted of a 1:1 mixture of the appropriate buffer and 
acetonitrile. The myoglobin tryptic digest standard mixture (500 pmol) was 
purchased from Alltech-Life Sciences (Deerfield, IL). 
 92
 Modification Reagents 
The peroxycarbonate reagents III-1a-1c were prepared according to the 
procedure in reference 16. The details of the preparation of III-1a were presented 
in chapter II. Reagents III-1b and III-1c were synthesized from their 
chloroformates as described below. 
 
Preparation of chloroformates 
 3-Nitrophenyl chloroformate  and 2-chloro-4-nitrophenyl chloroformate 
were prepared  from 3-nitrophenol and 2-chloro-4-nitrophenol respectively. The 
phenols and 1 equivalent of diisopropylethylamine as a solution in methylene 
chloride, were added slowly (over 10 min.) to 5 equivalents of phosgene (20%  
solution in toluene) at 0o C under argon gas. The reactions were stirred for 3 
hours at room temperature. The excess phosgene was removed by sparging with 
argon gas for 2 hours. The solvent was removed using under vacuum and the 
crude material was used in the preparation of the peroxycarbonates (III-1b and 
III-1c). 
 
Preparation of reagents III-1b and III-1c 
 The crude chloroformates (approximately 10 mMoles) were dissolved in 
20 ml of methylene chloride. The solutions were cooled to 0o C under nitrogen 
gas, and 1 equivalent of t-butyl hydroperoxide was added (5 M solution in 
dodecane). To the reaction mixtures, 1 equivalent of pyridine was added 
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dropwise over 10 min. The reactions were stirred at 0o C for 1 hour and allowed 
to reach room temperature. The solution was concentrated and purified by silica 
gel column chromatography (1:10 methanol/chloroform). The products III-1b and 
III-1c were obtained as light yellow solids in 40-50% yield. III-1b 1H-NMR (300 
MHz, CDCl3): 1.43 (s, 9H), 7.63 (m, 2H), 8.17 (m, 2H). 13C-NMR (75 MHz, 
CDCl3): 26.33, 85.73, 117.06, 121.73, 127.57, 130.77,145.2, 151.27, 152.70. III-
1c  1H-NMR (300 MHz, CDCl3): 1.41 (s, 9H), 7.47 (d, 2H, J = 8.7 Hz), 8.21 (ddd, 
2H, J1 = 9.0 Hz, J2 = 2.7 Hz, J3 = 0.6 Hz), 8.37 (d, 2H, J = 3.0 Hz). 13C-NMR (75 
MHz, CDCl3): 26.30, 86.14, 123.80, 124.26, 126.63, 128.64, 146.5, 151.64, 
162.74. Low resolution ESI mass spectrometry analysis for III-1b: calculated 
mass: 278.06 (M+Na+), observed mass: 278.00. Attempts to obtain a molecular 
ion for reagent III-1c in mass spectrometry analyses were unsuccessful. 
Nevertheless, reactions involving this reagent and the N-terminal amino groups 
of peptides led to adducts identical to those derived from reagents III-1a and III-
1b. 
 
Preparation of reagent III-2  
2-bromo-2-methylpropane-d9 was dissolved in anhydrous methylene 
chloride and an excess of anhydrous hydrogen peroxide in ether was added (~3 
fold excess). The resulting solution was cooled to 0oC at which point 1 equivalent 
of silver triflate was slowly added and the reaction mixture was allowed to stir at 
0oC for 4 hours. The mixture was filtered to remove the solid silver bromide and 
the filtrate was washed with fresh methylene chloride. The organic layer was 
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washed with water (2X), brine (1X) and dried over anhydrous MgSO4. The 
resulting solution was concentrated to approximately ½ of the original volume. 
Caution is advised since removing all solvent may result in explosion. The 
material was verified by TLC (SiO2, CH2Cl2) against t-butyl hydroperoxide 
(peroxide stain development). The resulting solution was added slowly to a 
methylene chloride solution of 3-nitrophenyl chloroformate at 0oC followed by 1 
equivalent of triethylamine. The reaction was allowed to reach room temperature 
and stirred for an additional hour. The solution was washed with 1% H2SO4 (2X), 
brine (1X) and dried over anhydrous MgSO4. The product was purified by silica 
gel column chromatography (1:1 hexane/ether) to give a white solid. 1H-NMR 
(300 MHz, CDCl3): 7.60 (m, 2H), 8.15 (m, 2H). 13C-NMR (125 MHz, CDCl3): 
24.95 (septet, J = 19.4 Hz), 85.7, 116.71, 121.83, 127.40, 130.28, 151.19, 
152.65. Calculated exact mass: 264.1308, HRMS (FAB) observed mass: 
264.1049. 
 
Modification Reactions 
  Reactions with all 20 amino acids as methyl, ethyl, or t-butyl ester 
derivatives were carried out by combining  5 μl of amino acid solution (0.1M in 
50/50 acetonitrile and water), 20 μl of ammonium bicarbonate buffer system 
(50/50 acetonitrile/buffer), and 20 μl of  III-1a (0.l M in acetonitrile). Final 
concentrations for amino acids and reagent were 0.01M and 0.04M respectively. 
Reactions were incubated at room temperature overnight. The crude reaction 
mixtures were diluted to 1 ml with a 0.4 mM solution of LiCl in methanol for MS 
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analysis.The peptide YRVRFLAKENVTQDAEDNC (entry 21 in Table III-2) was 
modified at pH range 5.2 to 8.6 by addition of 10μl of buffer system (50/50 
acetonitrile/buffer) to 10 μl of peptide solution (1mg/ml in water), followed by 5μl 
of III-1a or III-1b (0.1M in acetonitrile). Final concentrations of peptide and 
reagent were 0.7 μM and 33 M respectively. The reaction was incubated at 37 
oC for 1 hr.  The crude mixtures were analyzed by reverse phase LC-MS to 
determine selectivity for N-terminus modification. A series of peptides bearing 
each of the 20 amino acids at the N-terminus (Table III-2) were modified using 
the conditions which gave best selectivity for N-terminus modification (pH 5.5 
buffer system, reagent III-1b). All peptide reaction mixtures were diluted to 1 ml 
with a 0.1 % acetic acid solution and analyzed by ESI-MS/MS as direct liquid 
infusions and by MALDI-TOF. 
 
Mass spectrometry 
Mass spectrometry analyses of modified single amino acid derivatives and 
peptides were performed on a ThermoFinnigan (San Jose, CA) TSQ 7000 triple-
quadrupole instrument, equipped with an Electrospray Ionization (ESI) source 
and a Waters (Milford, MA) Alliance HPLC system . The capillary temperature 
was kept at 200 oC with a voltage of 20V. The electrospray needle voltage was 
4.5 kV, and the tube-lens voltage was maintained between 70 and 100 V. The 
sheath and auxiliary gases (N2) were adjusted to maximize signal.  The offset 
voltage in CID experiments varied between 20 and 35 eV. Samples were 
introduced into the ESI source as either lithium solutions or acidic solutions at a 
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rate of 10 to 20 μl/min in direct liquid infusion experiments. For LC-MS analyses 
of peptides, a Supelco (Bellefonte, PA) Discovery C18 column was used (25cm x 
4.6mm, 5μm). The solvent conditions consisted of a 20 min. gradient from 5% to 
50% solvent B (95% acetonitrile, 5% water, 0.05% TFA) into solvent A (95% 
water, 5% acetonitrile, 0.05% TFA). LC-MS/MS analyses of peptide derivatives 
were performed on a ThermoFinnigan (San Jose, CA) LCQ Deca XP ion trap 
instrument, equipped with an ESI source, and a HP Agilent (Palo Alto, CA) HPLC 
system. Instrument parameters were tuned using angiotensin II peptide (5 pmol) 
to maximize signal.  LC-MS/MS analyses of the myoglobin digests were 
performed using a Grace Vydac (Hesperia, CA) C18 column (10cm x 1mm x 
5μm). Solvent conditions consisted of a 30 min. gradient from 100% solvent A 
(5% acetonitrile, 95% water, 0.5% acetic acid) to 100% solvent B (5% water, 
95% acetonitrile, 0.5 % acetic acid).  MALDI studies for the peptides in Table III-6 
were carried out on an Applied Biosystems (Foster City, CA, USA) Voyager DE 
STR instrument. The myoglobin tryptic digest was analyzed by MALDI using an 
Applied Biosystems (Foster City, CA, USA) 4700 Proteomics instrument, 
equipped with a TOF-TOF mass analyzer.  The matrix for all analyses was α-
cyano-4-hydroxycinnamic acid (a solution in 4:6 0.1%TFA and acetonitrile). 
Samples were spotted on a gold target plate (1μl 1:1 matrix/ sample mixture) 
 
Modified myoglobin tryptic digest 
Modification of a myogobin tryptic digest standard was achieved by 
combining 50 μl of digest solution (500 pmol in 200 μl of water), 50 μl of acetate 
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buffer system (pH 5.5), and 25 μl of reagent III-1c (0.1M in acetonitrile). The 
reaction was incubated at room temperature for 2 hours and analyzed by reverse 
phase LC-MS/MS.  MS/MS data were analyzed with the SALSA algorithm29 to 
search for  modified peptides and neutral losses of N-terminal amino acid side 
chains. The modified peptide mixture was also analyzed by MALDI-TOF-TOF to 
obtain MS/MS spectra for imine peptide ions. 
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CHAPTER IV 
 
GAS-PHASE FRAGMENTATION OF ORNITHINE PEROXYCARBAMATES 
AND CHEMICAL CLEAVAGE OF PROTEINS VIA HYDRAZINOLYSIS 
 
Introduction 
With the goal of developing a gas-phase protein digestion technique to 
facilitate top-down proteomics approaches, we investigated the effect of 
introducing ornithine peroxycarbamates into peptide sequences on CID 
fragmentation patterns. Ornithine is not a natural occurring amino acid; however, 
it is an essential intermediate in the biosynthesis of L-arginine and plays an 
important role in the disposal of excess nitrogen through the urea cycle.1 In the 
urea cycle, arginine is converted to ornithine by the enzyme arginase, resulting in 
the release of urea. Ornithine can undergo lactamization under basic conditions, 
the stable six-member ring system formed makes this process favorable 
(Scheme IV-1).2  
 
H2N COO-
H2N
O
NH
O
H2N CO2
Ornithine
 
Scheme IV-1. Lactamization of ornithine in solution. 
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 In peptides, lactamization of ornithine may lead to backbone cleavage in 
solution.3 Lysine however, having an extra methylene group in the side chain, 
would lactamize through a seven-member ring, which is an unfavorable process.  
Based on this knowledge, we hypothesize that ornithine may offer site-specific 
peptide cleavage in the gas-phase. In addition, ornithine peroxycarbamates may 
promote more selective peptide backbone cleavage than their lysine analogues. 
A schematics of possible gas-phase radical-promoted fragmentation pathways 
for orninyl peroxycarbmate peptides is shown in Scheme IV-2. 
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Scheme IV-2.  Possible gas-phase radical pathways for ornithyl peroxycarbamate peptides. 
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 Ornithine can be introduced into peptide sequences via hydrazinolysis.4, 5 
Hydrazinolysis was first reported as a method for identifying the C-termini of 
proteins by Akabori and his collaborators.6, 7 It was also found that in this 
reaction, the guanidino group of arginines was hydrolyzed to the amine, resulting 
in the formation of ornithine.  In addition, hydrazinolysis of proteins has been 
found to preferably cleave at the C-terminal side of asparagine and at glycine-
glycine linkages.8, 9  Based on these studies, not only is hydrazinolysis valuable 
as a mean to introduce unnatural ornithine in peptide sequences, but also it’s 
application as a protein digestion technique deserves attention.  
In this chapter, we report on the effect of introducing ornithine and 
ornithine peroxycarbamates into peptide sequences on backbone fragmentation 
by CID. Moreover, we explore the use of hydrazinolysis as a protein degradation 
technique for top-down proteomics approaches. 
 
Results and Discussion 
 
Model Ornithine Peroxycarbamate Studies 
 N-α-acetyl ornithine, and its methyl and ethyl ester derivatives were 
modified as peroxycarbamates under conditions used for lysine modifications 
(1:1 0.1 NH4HCO3/ acetonitrile) as shown in Scheme IV-3.  The methyl and ethyl 
ester derivatives were prepared by treatment of N-α-acetyl ornithine with tosic 
acid and either methanol or ethanol.  All peroxycarbamate derivatives were 
subjected to CID as lithiated solutions using an ESI-triple quadrupole mass 
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spectrometer. The fragmentation of the model ornithine peroxycarbamate methyl 
ester is shown in Figure IV-1 and Figure IV-2. This fragmentation pattern was 
consistent with the other ornithine derivatives and was independent of counter 
ion (Na+, H+ and Ag+ gave similar CID spectra). The formation of the aminyl 
radical IV-4 is reminiscent of lysine peroxycarbamate studies.  Fragments IV-6 
and IV-7 are also expected based on lysine peroxycarbamate fragmentation; 
however, fragment IV-5 is unique to ornithine peroxycarbamates. This fragment 
has precedent in the autohydrolysis of peptides containing ornithinine and α-γ-
diaminobutyric acid (DABA) in solution.10 Under basic conditions the side chain 
amino group can attack the backbone carbonyl group to form a stable 5-member 
ring in the case of DABA, and a six-member ring in the case of ornithine, 
resulting backbone cleavage. Such intramolecular substitutions to form five and 
six-member rings are favorable. In the case of lysine, this process is not likely 
due to the formation of a seven-member ring. Thus the introduction of DABA or 
ornithine in peptide sequences has the potential for site specific peptide cleavage 
in solution, and this has been recognized by several researches in the past.2, 11 
Figure IV-1 shows that at low CID off-set voltages the predominant species is the 
aminyl radical IV-4, as expected based on lysine peroxycarbamate studies.  As 
the off-set increases, this aminyl radical diminishes, and fragments IV-5-7 
increase in intensity, suggesting the aminyl radical is likely to be an intermediate 
to IV-5-7. We note that none of the fragments in Figure IV-1 however are present 
in the CID spectra of ornithine derivatives not bearing a peroxycarbamate.  CID 
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fragmentation data for all ornithine peroxycarbamate derivatives is shown in  
Table IV-1. 
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Scheme IV-3. Modification of N-α-acetyl-ornithine-methyl ester as a peroxycarbamate. 
 
 
 
 
 
Figure IV-1. CID fragmentation of ornithine peroxycarbamate methyl ester. Effect of CID off-set 
voltage on ion intensities. 
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 Figure IV-2. CID spectrum of  ornithine methyl ester peroxycarbamate derivative IV-3. 
 
 
 Table IV-1. CID fragmentation of model ornithine derivatives. 
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                                 R(PC) = -(CH2)3NH(CO)OOtBu. 
 
 
Introduction of Ornithine in Peptide Sequences 
 In order to study the CID fragmentation of ornithine peptide 
peroxycarbamates we introduced ornithine into peptides by hydrolysis of 
arginines via a modified Akabori reaction. The Akabori reaction was introduced in 
the 50’s as a method for identifying C-terminal amino acids of linear peptides.6 In 
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this reaction, peptides are treated with anhydrous hydrazine at 125 oC for several 
hours. The result is the degradation of the peptides, where the C-terminal amino 
acid is liberated as the free acid and the rest are converted to hydrazides (                      
Scheme IV-4). The hydrazides can then be removed from the mixture as water-
insoluble compounds by treating with benzaldehyde.  Other researchers 
employed microwave technology to reduce the reaction time.5 In these later 
studies it was shown that by treating peptides with 50-70% aqueous hydrazine 
and microwave irradiation, Akabori cleavage products were obtained in 30 min. 
In addition, in the first few minutes of microwave irradiation, arginines were 
converted to ornithines. We used this method to introduce ornithine into 
commercially available peptides containing 1 or 2 arginines.  We found that 
arginines were converted to ornithine in the first 10 minutes of microwave 
irradiation.  An example is shown in Figure IV-3. 
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                         Scheme IV-4. Akabori reaction of a tripeptide. 
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Figure IV-3. MS spectrum showing conversion of Arg to Orn for peptide MEHFRWG (m/z = 962, 
[M + 1H]+) Ornithine derivative m/z = 920 [M – 42 + 1H]+. A) Microwave irradiation for 5 min. B) 
Microwave irradiation for 10 min.  
 
 
 
Ornithine Peptide Derivatives 
 
 A series of peptides modified as ornithine derivatives were converted to 
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2.  The ornithine peroxycarbamate peptides were then analyzed by ESI-LC-
MS/MS using a triple quadrupole and an ion-trap mass spectrometer.  The 
patterns of fragmentation obtained in MS/MS experiments did not resemble the 
fragmentation pattern observed for the model ornithine peroxycarbamates.  The 
fragmentation for these peptides was inconsistent and greatly dependant on 
peptide sequence. MS/MS fragmentation data for these peptides is given in 
Table IV-2. Although the CID spectra did differ from unmodified analogues, site-
specific sequence information was only obtained in very few cases. For example 
the peptide *MEHF(OrnPC)WG, were the asterisk represents an alkylated N-
terminus, and OrnPC refers to the ornithine peroxycarbamate derivative, lead to 
selective fragmentation at the C-terminal side of ornithine (fragments b5, and y2) 
and at the  N-terminal side of ornithine (fragment a4). However this was not the 
case for most peptides, and this fragmentation was not unique to the 
peroxycarbamate derivative, the unmodified peptide *MEHF(Orn)WG gave a 
similar fragmentation pattern.  In addition for several peptides, the fragments 
were difficult to assign. Based on these studies, we concluded that ornithine 
peroxycarbamates did not offer any advantages over lysine peroxycarbamates in 
terms of promoting site specific peptide cleavage.   
We also investigated fragmentation patterns of ornithine peptide 
derivatives not bearing peroxycarbamates compared to their arginine analogues. 
MS/MS data for these peptides is given in Table IV-3. The CID fragmentation of 
these ornithine peptide derivatives in very few cases exhibited preferred 
cleavage at ornithine compared to their arginine analogues; however, similarly to 
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ornithine peroxycarbamates, the fragmentation patterns were dependant on 
peptide sequence.   
 
 
Table IV-2. CID data for peptide ornithine peroxycarbamate derivatives and their unmodified 
analogues. 
 
Peptide CID Fragments CID Fragments of 
Unmodified Peptide 
*MEHF(OrnPC)WG y2, b5, a4 y2, b5+2, b3, b6+2, a4, b4, b5 
*Q(OrnPC)P(OrnPC)LSHK*GPMPF ----------------------------------------- y4, y4+2, y11 
*YGGFL(OrnPC)KYPK ----------------------------------------- y3, b5, y4, y6, y9 
*FHPK*(OrnPC)PWIL ----------------------------------------- y3, y7 
*D(OrnPC)VYIHPF NH2rad+2, NH2rad, y6, y7 – H2O y6, y6+2 
*HPK*(OrnPC)PWIL y7 - NH3 b7+2, y7+2, y7 
*N(OrnPC)VYVHPF y7 - NH3+2, y7 - NH3,  NH2rad+2 y3, y6 
 
(ornPC) represents ornithine peroxycarbamate. The asterisk represents site of alkylation 
(dimethyl amine) at the N-termini and lysine side chains. The unmodified peptides are those not 
bearing a peroxycarbamate (tBuOO(CO)-) moiety. 
 
 
  To test whether ornithine could provide a site for specific peptide 
cleavage in solution, we treated the ornithine containing peptide MEHF(Orn)WG 
with triethylamine at 65 oC and analyzed the crude reaction mixture by LC-MS. 
Previous studies on ornithine containing tri-peptides such as  Orn-Gly-Gly  
treated under these conditions have shown lactam formation leading to peptide 
cleavage at ornithine after 36 hours.3  However, we found no evidence of 
cleavage products for our ornithine containing peptide. We note that in the 
mentioned literature study, it was also found that the tendency for peptide 
cleavage via lactam formation decreased from a model ornithine methyl ester to 
the ornithine amide to the tri-peptide Orn-Gly-Gly. Which may explain why we did 
not see this peptide cleavage with a 7-mer.  
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Table IV-3.  CID fragmentation for peptide ornithine derivatives.   
 
CID Fragments CID Fragments of Ornithine 
Derivatives  
MEHFRWG b2, y5+2, y4, y5, y6  y2, b5 
HPKRPWIL y7+2, y5, y6, y7 b4, y6, y7 
DRVYIHPF b5, b6, y7, [M – H2O]+ y4, y5, b6, y6, y7, [M – H2O]+ 
NRVYVHPF b5, b6, b7 + H2O, [M – NH3]+ y4, b6 – NH3, b6, y6, [M – NH3]+ 
  
Ornithine derivatives are those where argenines have been converted to  
ornithine by treatment with hydrazine. 
 
 
Hydrazinolysis of Proteins 
The hydrazinolysis of proteins and it’s utility in protein sequencing has 
literature precedent in earlier decades (early 50’s to late 80’s).6, 7, 12-15 However, 
with the development of powerful mass spectrometry based protein sequencing 
techniques in the 90’s, the research in hydrazinolysis ceased. With the current 
need for improvements in top-down proteomics approaches, methods which 
allow partial degradation of proteins prior to top-down mass spectrometry 
analyses are of great value.  Studies on the specificity of hydrazine cleavage 
have shown that asparagine and glycine-glycine linkages are the most 
susceptible to hydrazinolysis.8, 9 The susceptibility of Asn linkages to 
hydrazinolysis is proposed to be due to the conversion of the side chain amide to 
the hydrazide, which leads to cyclization to form an acylaminosuccinyl hydrazide 
(Scheme IV-5).8 Based on these findings, we studied the applications of this 
specificity as well as the use of milder hydrazinolysis conditions to obtain partial 
degradation of large proteins such as Bovine Serum Albumin (BSA) and Human 
Serum Albumin (HSA) to facilitate top-down sequencing.  In order to study the 
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hydrazinolysis of BSA and HSA we used the microwave reaction method 
described by Bose et al.5 used for conversion of arginines to ornithines as 
described in the previous section.  Such conditions allow for slower degradation 
of peptides and therefore the opportunity to control the extent of degradation.  
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Scheme IV-5. Proposed mechanism of asparagine peptide bond cleavage by hydrazine. 
 
 
 
Hydrazinolysis Reactions 
BSA and HSA were treated with different amounts of hydrazine (10% to 
80%) and irradiated in a domestic microwave (600 watts) for different time 
intervals (2 min. to 60 min.). After hydrazine removal, the protein was analyzed 
by SDS-PAGE to determine the extent of protein cleavage. We found that 
conditions of 35% aqueous hydrazine, and irradiation for 10 min. allowed for 
partial degradation of the protein into large fragments (>10 KDa). However, the 
presence of trace amounts of hydrazine in the protein samples caused the 
samples to form a streak pattern on the gels, leading to poor resolution. Attempts 
were made to resolve this issue by treating the protein samples with 1% 
mercaptoethanol and SDS prior to hydrazinolysis as suggested in the literature5; 
however, there was no increase in gel resolution. Cleaning the protein samples 
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with C-18 spin micro columns or zip-tips prior to SDS-PAGE analysis resulted in 
significant loss of material.  Subjecting the hydrazine treated protein samples to 
long periods of in vacuo hydrazine removal afforded the best results.  The gel 
band pattern for the best analysis for hydrazine treated BSA and HSA is shown 
in Figure IV-4. The BSA and HSA fragment bands were excised, digested with 
trypsin and analyzed by LC-MS/MS to determine their sequence. 
 
250 KD
75
37
15
150
M      a      b      c                d
 
Figure IV-4. SDS-PAGE of proteins undergoing hydrazinolysis 
with 35% hydrazine irradiated for 10 min. M) Protein standards,  
a) Control BSA, b) Control HSA, c) BSA after hydrazinolysis, d) 
HSA after hydrazinolysis. 
 
 
LC-MS/MS Analysis of Partially Degraded BSA and HSA 
In order to determine the sites of cleavage afforded by hydrazinolysis, 
bands form the best SDS-PAGE gels were excised, and an in-gel tryptic 
digestion was carried out, followed by LC-MS/MS analysis. The MS/MS data was 
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analyzed by SEQUEST16 and P-Mod17 to identify the different protein fragments.  
In both cases (HSA and BSA) this analysis led to the identification of peptides 
belonging to many different sections of the protein sequence, instead of discrete 
sections that could be assigned to the large fragments observed by SDS-PAGE.  
It is possible that the resolution of the gels was still not sufficient to allow for 
excision of single bands, thus leading to samples containing multiple protein 
fragments. Figure IV-5 shows an example of sequence coverage from analysis of 
the 5th band (from top to bottom) on the SDS gel for hydrazine treated BSA.  
From this result it is evident that more than one fragment was included in the 
sample, since the majority of the protein sequence is represented in this band. 
 
MKWVTFISLLLLFSSAYSRGVFRRDTHKSEIAHRFKDLGEEHFKGLVLIAFSQYL
QQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETY
GDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGK
YLYEIARRHPYFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLA
SSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKEC
CHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEVEKDAIP
ENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEY
EATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNA
LIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCTKPESERMPCTEDYLSLILNRLC
VLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTL
PDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFA
VEGPKLVVSTQTALA 
 
 
 
 
 
Figure IV-5. BSA sequence coverage (red letters) for band 5 (top to bottom) from SDS-PAGE. 
 
 
Conclusion 
 Although studies on model ornithine peroxycarbamates indicate lactam 
formation and backbone cleavage in the gas-phase, peptide studies did not 
follow this trend. Peptide ornithine peroxycarbamates did not appear to lead to 
selective backbone fragmentation at ornithine, and did not offer any advantages 
in this respect compared to lysine peroxycarbamates.  Thus future efforts should 
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continue to focus on lysine peroxycarbamate chemistry.  The hydrazinolysis of 
proteins via microwave irradiation appears to result in partial protein degradation, 
leading to large protein fragments.  The SDS-PAGE analysis resulted in poor 
reproducibility and band resolution. 2D-SDS-PAGE may offer better band 
separation for proteomics analyses; however, a better method for hydrazine 
removal should be used to avoid streaky gel patterns and improve resolution. 
Nevertheless, hydrazinolysis has the potential to be used as a way to achieve 
partial cleavage of proteins prior to top-down sequencing analyses in order to 
facilitate protein fragmentation in the gas-phase, and yet retain the entire protein 
sequence. 
 
Experimental Procedures 
 
General 
 N-α-acetyl ornithine was purchased from Aldrich Chemical Co. 
(Milwaukee, WI, USA).  Peptides were purchased from American Peptide Co. 
(Sunnyvale, CA, USA).  BSA and HSA were obtained from Sigma (Milwaukee, 
WI, USA). All other reagents were purchased form Aldrich Chemical Co. Solvents 
were HPLC grade, purchased from Fisher Scientific (Pittsburgh PA, USA). t-
Butyl-4-nitrophenyl-peroxycarbonate was synthesized according to previous work 
in our laboratory (See chapter II).18   The NH4CO3 buffer system used for 
Ornithine peroxycarbamate modifications consisted of a 1:1 mixture of 0.1 M 
NH4CO3 (pH 8.6) and acetonitrile.  SDS-PAGE was performed using a 
NuPAGE® Novex Bis-Tris gel kit from Invitrogen (Carlsbad, CA, USA). LC-MS 
 116
analyses were carried out using a C-18 column (10 cm x 1 mm x 5um), from 
Grace Vydac (Hesperia, CA, USA).  In some cases, peptide and protein samples 
were purified using PepClean™ C-18 Spin columns purchased from PIERCE 
(Rockford, IL, USA) prior to MS analysis. Microwave irradiation was performed 
using a domestic Emerson microwave operated on high setting (600 watts). 
 
Model Ornithine Derivatives 
 The N-α-acetyl ornithine methyl and ethyl esters were prepared by 
combining N-α-acetyl ornithine (60 mg) with 1.2 equivalents of tosic acid in 
methanol (for the methyl ester) or ethanol (for the ethyl ester) and refluxing for 2 
hours. After removal of excess alcohol, the esters were analyzed by ESI-MS. 
Preparation of the model ornithine peroxycarbamates was carried out by addition 
of 0.1 g of ornithine derivative to 2 equivalents of the peroxycarbonate IV-2 in 1ml 
of 1:1 0.1 NH4HCO3/acetonitrile. 
 
Peptide Ornithine Derivatives 
 
Conversion of arginine to ornithine 
 Peptides (0.2 mg) were dissolved in 1 ml of 70% aqueous hydrazine in 
glass vials. The vials were placed in a domestic microwave and irradiated at full 
power (600 watts) for 30 min. Aliquots of 100 μl were obtained at intervals of 5 
min. The hydrazine was removed in vacuo and the samples were redisolved in 
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0.1% formic acid for LC-MS analysis. Complete conversion of arginine to 
ornithine was achieved after 10 minutes in most cases.  
 
Alkylation of N-termini and Lysines 
 Alkylation of free amino groups prior to hydrazinolysis was carried out 
following literature procedures.19 Peptides (0.2 mg) were combined with 200 μl of 
0.1M HEPES buffer (N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid), 
and 100 μl of 0.1 NaCNBH3 in HEPES. Formaldehyde (100 μl, 0.1M) was added 
and the reaction was allowed to stir at room temperature for 2 hours.  Solvent 
was reduced to 100 μl under vacuum and the samples were desalted using C-18 
spin columns.  Samples were dried under vacuum and subjected to treatment 
with hydrazine as described above. The excess hydrazine was removed by 
drying under vacuum followed by treatment with C-18 silica gel (C-18 spin 
columns). The eluted samples were then dried under vacuum for further 
derivatization. 
 
Peptide Ornithine Peroxycarbamates 
 The alkylated peptide ornithine derivatives were dissolved in 20 μl of water 
and combined with 20 μl of 1:1 0.1 NH4HCO3/acetonitrile, followed by addition of 
the peroxycarbonate IV-2 (20 μl 0.1M in acetonitrile). The reactions were allowed 
to incubate for 20 minutes and the crude mixtures were used in LC-MS analyses. 
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 Hydrazinolysis of Proteins 
 Several reactions were prepared with HSA and BSA (1 mg) dissolved in 
varied amounts of aqueous hydrazine (10 to 70% in 5% increments). The 
reactions were carried out in glass vials and these were subjected to microwave 
irradiation (600 watts) for 15 min. Because 35% aqueous hydrazine gave the 
best results (larger degradation fragments), another set of reactions were 
prepared with 35% aqueous hydrazine and irradiated at different time intervals (5 
to 60 min, 5 min. intervals). We found that 35% aqueous hydrazine and 
irradiation for 10 min. gave the best partial degradation of both BSA and HSA. All 
reactions were subjected to vacuum evaporation over night to remove excess 
hydrazine. The samples were then redisolved in SDS buffer for PAGE analysis.  
 
SDS-PAGE 
Gel analysis was carried out using a Bis-Tris gel kit from Invitrogen 
(Carlsbad, CA, USA).  Protein stock samples were approximately 1 mg/ml in 
SDS running buffer and 10 μl (10 μg) were loaded on to the gel. The gels were 
developed at a constant voltage of 200V for 30 min.  Visualization was done with 
coomassie blue stain. 
 
In-gel digestion 
The different bands present on the gel were excised and cut into small 
pieces. These gel pieces were transferred to 1.5 ml eppendorf tubes for tryptic 
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digestion. First the samples were incubated with 100 μl of 100 mM NH4HCO3 
buffer (pH = 7.0) for 15 min. They were then treated with 150 μl of 5 mM 
dithiolthreitol (DDT) in NH4HCO3 buffer for 15 min. at 55 oC to reduce disulfide 
linkages.  Iodoacetamide was then added to alkylate free sulfhydryl groups (10 
μl, 100 mM in NH4HCO3 buffer) and the samples were incubated in the absence 
of light for 15 min.  at room temperature.  After removal of reagent solution, the 
gel samples were washed 2X with a 1:1 acetonitrile/ NH4HCO3 buffer solution 
and dehydrated with 100μl of acetonitrile.  After removal of solvent, the gels were 
covered with 50 μl of a trypsin solution (0.01 mg/μl) in 25 mM NH4HCO3 buffer. 
The samples were incubated at 37 oC over night.  The liquid phase was collected 
and the gel was washed with 6:4 acetonitrile/0.1% TFA.  The combined liquid 
phase was dried under vacuum, and the digest peptides resuspended in 50 μl of 
0.1% formic acid for LC-MS analysis. 
 
Mass Spectrometry 
Mass spectrometry analyses of model ornithine derivatives and peptides 
were performed on a ThermoFinnigan (San Jose, CA) TSQ 7000 triple-
quadrupole instrument, equipped with an Electrospray Ionization (ESI) source 
and a Waters (Milford, MA) Alliance HPLC system . The capillary temperature 
was kept at 200 oC with a voltage of 20V. The electrospray needle voltage was 
4.5 kV, and the tube-lens voltage was maintained between 70 and 100 V. The 
sheath and auxiliary gases (N2) were adjusted to maximize signal.  The offset 
voltage in CID experiments varied between 20 and 35 eV. Samples were 
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introduced into the ESI source as either lithium solutions or acidic solutions at a 
rate of 10 to 20μl/min in direct liquid infusion experiments. For LC-MS analyses 
of peptides, a Supelco (Bellefonte, PA) Discovery C-18 column was used (25cm 
x 4.6mm, 5μm). The solvent conditions consisted of a 20 min. gradient from 5% 
to 50% solvent B (95% acetonitrile, 5% water, 0.05% TFA) into solvent A (95% 
water, 5% acetonitrile, 0.05% TFA). LC-MS/MS analyses of peptide derivatives 
were performed on a ThermoFinnigan (San Jose, CA) LCQ Deca XP ion trap 
instrument, equipped with an ESI source, and a HP Agilent (Palo Alto, CA) HPLC 
system. Instrument parameters were tuned using angiotensin II peptide (5 pmol) 
to maximize signal.  LC-MS/MS analyses of the hydrazine treated BSA and HSA 
tryptic digests were performed using a Grace Vydac (Hesperia, CA) C-18 column 
(10cm x 1mm x 5μm). Solvent conditions consisted of a 30 min. gradient from 
100% solvent A (5% acetonitrile, 95% water, 0.5% acetic acid) to 100% solvent B 
(5% water, 95% acetonitrile, 0.5 % acetic acid).   
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                                             CHAPTER V 
 
DISSERTATION SUMMARY 
 
The development of new and improved mass spectrometry techniques 
over the last decade has allowed the rapid improvement of proteomics analyses. 
Bottom-up shot-gun proteomics has become the most automated, widely used 
technique in protein identification.1 The use of multi-dimensional 
chromatographic separations online with mass spectrometry, allows for 
hightroughput analyses. In addition, the availability of large protein databases 
and sophisticated database search algorithms make possible identification of 
multiple proteins in a biological system. However, protein identification is only a 
part of proteomics research, a great part of proteomics is focused on protein 
function and interactions, which are significantly influenced by post-translational 
modifications.2  Protein identification in bottom-up proteomics requires only a few 
matching peptide sequences. However to obtain information on post-translational 
modifications it is advantageous to have access to the entire protein sequence.3 
This is seldom possible using bottom-up approaches since a great part of the 
protein may be lost in the analysis.4 In order to solve this problem, top-down 
strategies have been developed more recently, where the entire protein 
sequence is interrogated by mass spectrometry. This requires fragmentation of 
intact proteins using powerful mass spectrometers such as an FT-ICR.5  
Although such techniques have proven to be extremely useful in retaining the 
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intact protein and therefore allowing 100% sequence coverage, fragmentation of 
large proteins remains challenging. Thus techniques which facilitate this process 
and yet minimize protein degradation prior to mass spectrometry analysis are 
very valuable. The work presented in this dissertation has the goal of improving 
top-down proteomics by developing techniques to enhance protein fragmentation 
in the mass spectrometer.  
 
Lysine Peroxycarbamates 
Research on lysine peroxycarbamates involves the chemical modification 
of lysine residues with a labile peroxy group to induce fragmentation in the gas-
phase at or near the site of modification.  CID studies carried out on a model 
lysine peroxycarbamate showed that this dissociated to form an aminyl radical, 
which leads to backbone and side-chain fragmentation (Scheme V-1).  The study 
was extended to peptides containing lysine peroxycarbamates. Where CID 
resulted in the formation of a-, b-, c-, and z-type ions.  These ions however are 
accompanied by fragments resulting from side chain degradation which do not 
result in backbone cleavage.  
MALDI studies on peroxycarbamate modified peptides differed from ESI 
studies in that peptide fragmentation occurred at the source without the need for 
CID. However, the intact peptide peroxycarbamate adducts were not observed. 
MALDI studies offer the advantage of working with singly charged species, which 
facilitates data interpretation. In addition, peptide fragments are obtained without 
an MS/MS experiment. However a combination of both ESI and MALDI would 
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provide a more complete analysis by allowing interrogation of the intact 
peroxycarbamate adducts and yet obtain clean fragmentation spectra.  
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Scheme V-1. Modification of lysine model as a peroxycarbamate and fragmentation by CID. 
 
Studies on lysine peroxycarbamates of ribonuclease A (~ 14 kDa) were 
more complex than peptide analyses due to a greater number of lysine 
modifications.  In order to simply interpretation of fragmentation data, we 
adjusted modification conditions to allow for only 1 to 2 lysine peroxycarbamate 
adducts, and isolated these by cation-exchange chromatography. ESI-CID of 
these adducts did not result in detectable protein fragmentation. This is possibly 
due to the presence of multiple lysine peroxycarbamate regioisomers. MALDI 
studies also did no lead to fragmentation, however dissociation of the t-butyl 
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peroxy group was observed. More powerful mass spectrometers such as an FT-
ICR may be necessary to achieve protein fragmentation in this manner. 
 
N-terminal peroxycarbamates 
Despite all the advances in shot-gun proteomics, de novo protein 
identification continues to be a useful tool for the study of proteins derived from 
unknown genomes, as well as for highly post-translationally modified proteins.6  
De novo interpretation of MS/MS spectra can be cumbersome, and for this 
reason several techniques have been developed to manipulate peptide 
fragmentation patterns.7-17 Our work involves the extension of the lysine 
peroxycarbamate chemistry to the modification of N-termini. Fragmentation of 
these N-terminal peroxycarbamates would lead the way to a mass spectrometry 
based N-terminus identification technique that would facilitate de novo analyses.  
 We found that CID experiments on peptides modified as 
peroxycarbamates at the N-terminus lead to cleavage of the N-terminal side 
chain. This neutral loss can then be used to determine the identity of the amino 
acid (Scheme V-2). Isobaric peptides were distinguishable in this manner without 
the need to elucidate the entire sequence.   
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Scheme V-2. CID fragmentation of N-terminal peroxycarbamates. 
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Furthermore, cleavage of the N-terminal side chain of peptides led to a 
labeled b-ion series in MS3 experiments (Scheme V-3).  N-terminal amino acid 
identification was also achieved in the analysis of modified peptides from 
myoglobin tryptic digest, which suggested this method was suitable in a 
proteomics setting. 
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Scheme V-3. Labeling of b-ion series by MS3 of N-terminal peroxycarbamates. 
 
N-terminal side chain loss was also observed in MALDI studies. However, 
as for the lysine peroxycarbamates, MALDI did not produce intact peptide 
peroxycarbamate adducts, and N-terminal side chain loss occurred at the source. 
The presence of singly charged ions facilitated identification of N-terminal amino 
acids.   All of these findings suggest this N-terminus identification technique has 
the potential to be used as a tool in de novo sequencing. In addition, the 
distinction of isobaric peptides by the N-terminus is a useful technique in peptide 
mass fingerprinting, where identification of the N-termini can be use to narrow 
database searches.14 
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Ornithine Peroxycarbamates 
Although lysine peroxycarbamates lead to peptide backbone 
fragmentation upon CID, there is a significant amount of fragmentation that does 
not lead to backbone cleavage. With the goal of obtaining more selective peptide 
cleavage, we investigated the CID fragmentation patterns of ornithine 
peroxycarbamates. Ornithine is an unnatural amino acid which plays an 
important role in the urea cycle.18  It has been found in the past that introduction 
of ornithine and 2,4-diaminobutanoic acid (DABA) into peptides can lead to 
peptide cleavage in solution by lactamization of the side chain (Scheme V-4).19-21 
With this in mind, we examined the effects of introducing ornithine and ornithine 
peroxycarbamates in peptides on CID fragmentation.  
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Scheme V-4. Lactamization of Ornythinyl peptides. 
 
We introduced ornithine in peptides by hydrazinolysis, where arginine side 
chains are hydrolyzed to give ornithine (Scheme V-5).22 In CID experiments of 
ornithine peroxycarbamate model derivatives we found significant fragmentation 
at the C-terminus by lactamization of the side chain.  However these results were 
unique to the model amino acid and did not carry to the study of peptides 
containing ornithine peroxycarbamates. In the case of peptides, CID 
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fragmentation patterns were greatly dependant on the peptide sequence and we 
did not observe tendency for cleavage at the ornithine or ornithine 
peroxycarbamate sites.  Thus the introduction of ornithine peroxycarbamates in 
peptides did not provide any advantages in peptide backbone cleavage by CID 
compared to lysine peroxycarbmates. 
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Scheme V-5. Conversion of arginine to ornithine. 
 
Hydrazinolysis of Proteins 
 Although fragmentation of intact proteins by FTICR has come a long way 
in the past few years, direct fragmentation of large proteins remains challenging.5 
For this reason, techniques that facilitate this process are necessary. 
Hydrazinolysis of proteins has been investigated in the past by Akabori and 
coworkers as a C-terminus identification technique, leading to naming of this 
process the Akabori reaction (Scheme V-6).23, 24 Other researchers have found 
that asparagine linkages are particularly susceptible to hydrazinolyis.25, 26 In this 
work we explore the use of hydrazinolysis as a technique for partially degrading 
large proteins with the goal of improving top-down proteomics approaches.  
 130
H2N CHC
R1
O H
N CHC
R2
O H
N CHC
R3
OH
O
CHC
R3
OH
O
H2NH2N CHC
R1
O
NHNH2 H2N CHC
R2
O
NHNH2
NH2NH2
CHC
R3
OH
O
H2NN CHC
R1
O
NHN N CHC
R2
O
NHNCHPhPhHC PhHC CHPh
PhCHO
Water-insoluble amino acids
C-terminus
 
Scheme V-6. The Akabori reaction for identification of C-terminus. 
 
We found that using a modified akabori reaction procedure involving 
microwave irradiation, allowed for better control of the extent of protein 
cleavage.22 By adjusting reaction time and hydrazine concentration, we were 
able to obtain partial degradation of BSA and HSA into large protein fragments 
that can then be used for top-down analyses. Complete characterization of these 
protein fragments proved to be challenging; Nevertheless, hydrazinolysis has the 
potential to be used as a chemical protein degradation technique to facilitate 
FTICR analyses, and yet retain access to the entire protein sequence. 
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Concluding Remarks 
 
The research presented in this dissertation introduces valuable concepts 
for the improvement of proteomics. We have shown that lysine 
peroxycarbamates induce site-specific peptide fragmentation in the gas-phase. 
We have also shown that N-termini peroxycarbamates can be used to identify N-
terminal amino acids and label b-ion series in MS/MS spectra of peptides. 
Although the lysine peroxycarbamate chemistry at the protein level remains to be 
further explored, preliminary results show that it is feasible to control the extent of 
lysine modification in order to aid MS data interpretation.  Future studies that may 
take this technique further should involve the analysis of modified proteins by FT-
ICR.  This mass spectrometry technique has been successful in obtaining 
MS/MS spectra of proteins up to 60 KDa.5, 27  
Our studies on hydrazinolysis of BSA and HSA show that this reaction can 
be used to break down the proteins into smaller, yet still protein-size sections. 
FT-ICR offers best MS/MS fragmentation efficiency for small proteins (5 – 20 
KDa).5, 27  Therefore by pre-treating large proteins with hydrazine we can greatly 
increase the amount of sequence information obtained in a top-down analysis.  
Future work in this area will require an extensive proteomics study to determine 
consistent patterns of protein cleavage by hydrazine.  
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